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Summaries 
SUMMARY 
Mycotoxins are 'fungal metabolites which when ingested, inhaled or absorbed through the 
skin, cause lowered performance, sickness or death in man or animals, including birds' (Pitt, 
1996). Mycotoxins occur in a wide variety of foods and feeds and have been implicated in a 
range of human and animal diseases. Exposure to mycotoxins can produce both acute and 
chronic toxicities ranging from death to deleterious effects on the central nervous, cardio-
vascular and pulmonary systems, and on the alimentary tract. They may be carcinogenic, 
mutagenic, teratogenic and immunosuppressive. The ability of some mycotoxins to compro-
mise the immune response and consequently, to reduce resistance to infectious disease, is 
now widely considered to be their most important effect. Furthermore, it is the opinion of 
some that the elimination of mycotoxins would be the single most effective and beneficial 
change which could be made in human diets around the world. 
The mycotoxins attract world-wide attention because of the significant economic losses 
associated with their impact on human health, animal productivity and both domestic and in-
ternational trade. lt has been estimated that annual losses in the US and Canada arising from 
the impact of mycotoxins on the feed and livestock industries, for example, are in the order of 
US$ 5 billion. In developing countries where food staples (e .g. maize and groundnuts) are sus-
ceptible to contamination, there are likely to be significant additional losses amongst the 
human population because of morbidity and premature death associated with the consumption 
of mycotoxin-contaminated food. 
The contraints and opportunities associated with the control of moulds and mycotoxins are 
addressed by adopting a 'systems' approach. The Mycotoxicology System is described in terms 
of interacting commodity, spoilage, mycotoxin, socio-economic and control subsystems; the 
main components of the control subsystem are considered under the titles (a) idendification of 
quality constraints (b) prevention (c) identification and segregation of contaminated material 
and (d) detoxification. The metabolic fate of selected mycotoxins is discussed in detail as a 
background to the toxicity and biomonitoring of mycotoxins; the chemical detoxification of 
aflatoxin is also discussed in depth. 
The concept of Process Quality Management (PQM) which utilizes a Process-Commodity 
Matrix and a PQM Cycle to identify contraints and opportunities for interventions, and test the 
efficacy of the interventions, is introduced. 
Future research needs are also discussed. 
RESUME 
Les mycotoxines sont des 'metaboliques fongiques qui, lorsqu'ils sont ingreres, inhales ou 
absorbes par la peau, entralnent une performance reduite, la maladie ou le deces chez les 
humans ou les animaux, les oiseaux y compris' (Pitt, 1996). Les mycotoxines se trouvent dans 
une grande variete d'aliments pour humains et pour animaux et ant ete impliquees dans une 
gamme de maladies humaines et animales. L'exposition aux mycotoxines peut a la fois pro-
duire des toxicites aigues et chroniques, allant du deces a des effets deleteres chroniques sur 
le systeme nerveux central, les systems cardiovasculaire et pulmonaire et sur l'appareil diges-
tif. Elles peuvent etre carcinogenes, mutagenes, teratogenes et immunodepressives. La capacite 
de certaines mycotoxines a compromettre la reponse immune et, par consequent, a reduire la 
resistance aux maladies infectieuses, est actuellement consideree comme leur effet le plus 
important. En outre, !'elimination des mycotoxines pourrait, selon certains avis, etre la modifi-
cation la plus efficace et benefique a elle seule qui pourrait etre apportee aux regimes al imen-
taires humains de par le monde. 
Les mycotoxines attirent !'attention dans le monde entier a cause des pertes economiques 
significatives qui sont associees a leur effet sur la sante des humains, la productivite des ani-
maux et le commerce interieur et international. 11 est estime que les pertes annuelles aux 
Etats-Unis et au Canada dues a l'en des mycotoxines sur les industries des aliments pour ani-
.· 
maux et de l'elevage, par exemple, sont de l'ordre de 5 milliards de dollars E-U. Dans les pays 
en developpement, ou les al iments de base (ex: maYs et arachide) sont sensibles a la contami-
nation, il est probable que les petres supplementaires parmi la pupulation humaine soient sig-
nificatives a cause de la morbidite et de la mort prematuree associees a la consommation 
d'aliments contamines par les mycotoxines. 
Les contraintes et les possibilites associees au controle des moisissures et des mycotoxines 
sont abordees au moyen d'une approche de 'systeme'. Le Systeme de mycotoxicologie est 
decrit en termes de !'interaction des sous-systems de la denree, de la deterioration, des myco-
toxines, de controle de celles-ci et des facteurs economiques. Les elements principaux de la 
sous-systeme du controle sont examines sous les rubriques (a) identification des contraintes a 
la qualite (b) mesures de prevention (c) identification et segregation du materiel contamine, et 
(d) desintoxication. Le sort metabolique de mycotoxines selectionnees est aborde de fac;:on 
detaillee en tant que contexte pour la toxicite et la surveillance biologique des mycotoxines; 
la desintoxication chimique de l'aflatoxine est egalement discutee de fac;:on approfondie. 
Le concept de Gestion de la qualite du processus (PQM), qui utilise une matrice de la den-
ree du processus et un cycle de PQM afin d'identifier les contraintes et les possibilites d'inter-
ventions et de tester l'efficacite de ces interventions, est presente. 
Les besoins futurs en matiere de recherche sont aussi examines. 
RESUMEN 
Las micotoxinas son 'metabolitos fungales que, al ser ingeridos, inhalados o absorbidos a 
traves de la piel, producen una reducci6n en la capacidad funcional, sfntomas de enfermedad 
y aun la muerte de seres humanos y animales, incluyendo las aves' (Pitt, 1996). Las micotoxi-
nas se encuentran en una amplia variedad de productos alimenticios y piensos y han sido 
relacionadas con diversos tipos de enfermedad, tanto en seres humanos como en animales, 
que pueden llevar aun a la muerte del individuo afectado. La exposici6n a mictoxinas puede 
reultar en toxicidad aguda y cr6nica, con repercusiones nocivas tales como problemas cr6ni-
cos del sistema nervioso central y de Ios sistemas cardiovascular y pulmonar, asf como sobre 
el tubo digestivo. Su efecto puede ser carcinogenico, mutagenico e inmunosupresivo. En la 
actualidad, se considera como su efecto mas importante la capacidad de algunas mictoxinas 
para afectar la reacci6n de inmunidad del organismo y, consiguientemente, para reducir su 
resistencia a enfermedades infecciosas. Ademas, en opinion de algunos cientificos, la elimina-
ci6n de las micotoxinas serfa la transformaci6n individual mas eficaz y beneficiosa que podria 
ocurrir en la dieta del hombre en el mundo entero. 
Las micotoxinas han llamado la atenci6n por todo el mundo como resultado de las impor-
tantes perdidas exon6micas asociadas con su impacto sobre la salud humana, productividad 
animal y comercioi nacional e internacional. Se ha calculado que, en Ios Estados Unidos y 
Canada, las perdidas anuales atribuibles a las micotoxinas en el sector ganadero y de Ios pien-
sos asciende a unos USA$ 5000 milliones. En Ios paises en desarrollo, en donde productos ali-
menticios basicos tales como el mafz y el cacahuete se hallan expuestos a contaminaci6n, es 
probable que las micotoxinas reporten perdidas adicionales de importancia entre la poblaci6n 
humana, como resultado de la morbilidad y fallecimiento prematuro asociados con el con-
sumo de producios alimenticios contaminados con micotoxinas. 
Tanto las oportunidades como Ios impedimentos asociados con el control de Ios mohos y 
micotoxinas requieren la adopci6n de un planteamiento de 'sistemas'. El Si stem a 
Micotoxicol6gico se describe en terminos de la interacci6n de subsistemas tales como el pro-
ducto, su deterioro, las micotoxinas y Ios aspectos socioecon6micos y de control; estudian-
dose Ios principles componentes de la subsistema control bajo Ios titulos siguientes: (a) 
identificaci6n de las restricciones de calidad; (b) prevenci6n; (c) identificaci6n y segregaci6n 
del material contaminado y (d) desintoxicaci6n. A manera de informaci6n de fondo sobre la 
toxicidad y biosupervisi6n de las micotoxinas, se examina minuciosamente la suerte metab6-
lica de micotoxinas seleccionadas. Tambien se estudia con gran detalle la desintoxicaci6n 
qufmica de la aflatoxina. 
El articulo presenta el concepto de la gesti6n de Ios procesos (PQM), en el que se utiliza 
una matriz de procesos-productos y un Ciclo PQM para identifcar las restricciones y oportuni-
dades de intervenci6n y para probar la eficacia de las intervenciones. 
Finalmente, se examinan las exigencias de nuevos trabjos de investigaci6n. 
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What is a mycotoxin? 
Pitt (1996) recently defined mycotoxins as 'fungal metabolites which, when 
ingested, inhaled or absorbed through the skin, cause lowered performance, 
sickness or death in man or animals, including birds.' 
lt is likely that mycotoxins have plagued mankind since the beginning of 
organized crop production. For example, ergotism (St Anthony's Fire), which 
is caused by the consumption of rye contaminated with the 'ergot alkaloids', 
is discussed in the Old Testament, and reached epidemic proportions in 
many parts of Europe in the 1Oth century (Beardall and Miller, 1994). lt has 
also been surmised that the severe depopulation of western Europe in the 
13th century was caused by the replacement of rye with wheat, an important 
source of Fusarium mycotoxins (Miller, 1991 ). The development of the 
Fusarium toxins in over-wintered grain was responsible for the deaths of 
thousands of people, and the decimation of entire villages, in Siberia during 
World War Two. The mycotoxicosis latterly known as 'alimentary toxic aleu-
kia' (ATA) produced vomiting, acute inflammation of the alimentary tract, 
anaemia, circulatory failure and convulsions. 
Mycotoxins occur in a wide variety of foods and feeds and have been 
implicated in a range of human and animal diseases (Council for Agricultural 
Science and Technology, 1989). Exposure to mycotoxins can produce both 
acute and chronic toxicities ranging from death to deleterious effects on the 
central nervous, cardiovascular and pulmonary systems, and on the alimen-
tary tract. Mycotoxins may be carcinogenic, mutagenic, teratogenic and 
immunosuppressive. The ability of some of them to compromise the immune 
response and consequently reduce resistance to infectious disease, is now 
widely considered to be their most important effect. Some are of the opinion 
that the single most effective and beneficial change which could be made in 
human diets around the world would be the elimination of mycotoxins 
(Miller, 1996). 
The mycotoxins attract world-wide attention because of the significant 
economic losses associated with their impact on human health, animal pro-
ductivity and both domestic and international trade. lt has been estimated, 
for example, that annual losses in the US and Canada arising from the impact 
of mycotoxins on the feed and livestock industries are in the order of US$ 5 
billion (Miller, personal communication). In developing countries where the 
food staples (e.g. maize and groundnuts) are susceptible to contamination, 
significant additional losses amongst the human population are likely 
because of morbidity and premature death associated with the consumption 
of mycotoxins (seep. 11 ). 
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Mycotoxicology - a Systems 
Approach 
THE MYCOTOXICOLOGY SYSTEM 
A 'systems' approach allows a given situation (the system) to be viewed as a 
set of interacting components (subsystems) in which the interactions are just 
as important as the components themselves (after Open University Business 
School, 1987). A proposed systems approach to mycotoxicology is outlined 
(see Figures 1-4 and Figures 9-11) as a number of proposed conceptual 
models of interactions between, and within, Commodity, Spoilage, 
Mycotoxin, Socio-Economic and Control Systems. Within a system, the sub-
systems can freely interact; in other words, activity within one subsystem can 
influence events in one or more other subsystems. In each figure, the system 
is contained within the rectangular box and the interacting subsystems are 
represented by the ellipses. 
In Figure 1, the Mycotoxicology System is represented as interacting 
Commodity, Spoilage, Mycotoxin, Socio-Economic and Control Systems; 
each subsystem in Figure 1 is itself considered as a system in Figures 2-4 
and Figure 9. 
lt can be strongly argued that a better comprehension of both the interac-
tions and the components associated with these systems assists in understand-
ing the aetiology of mycotoxin production, and in formulating appropriate 
interventions for the control of mycotoxins and mycotoxicoses (see The 
Control System, p. 21) 
Figure 1 
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MYCOTOXICOLOGY SYSTEM 
A Systems approach to Mycotoxicology: Conceptual Models 
THE COMMODITY SYSTEM 
Any Commodity System (involving the production, marketing and utilization 
of the commodity) is composed of numerous interacting technical and socio-
economic 'processes' including, for example, pest and disease control, har-
vesting, drying, processing, marketing, credit and pricing policies, and cul-
tural issues. A generalized, simplified Commodity System is shown in Figure 
2; selected processes are represented as interacting subsystems. 
OTHER COMMODITY SYSTEMS 
THE COMMODITY SYSTEM 
~~~ 
~~ 
Figure 2 The Commodity System 
At any point within the Commodity System, the condition of the com-
modity is determined by a complex milieu involving a multitude of interac-
tions between the crop, the macro- and micro-environment and a variety of 
biological, chemical, physical and socio-economic factors. A change within 
any one process will invariably bring about changes in one or more of the 
other processes. For example, the current trend towards the dismantling of 
centralized, quasi-government grain stores and the concomitant increase in 
privately operated stores may, at least temporarily, reduce the overall stan-
dard of medium-scale storage. This situation may, in turn, both increase the 
need for the careful drying of grain before storage, and encourage processors 
to seek either recently harvested material and/or increase their own capacity 
for the storage of grain. Alternatively, processors may begin dealing directly 
with the farmers themselves, possibly influencing both pre- and immediate 
post-harvest practices. 
Similarly, since it is very rare for a single commodity system to exist in iso-
lation within a given agroclimatic region, it should be remembered that activities 
within one system can significantly effect events in other systems (see Figure 2). 
THE SPOILAGE SYSTEM 
Biodeterioration is the net result of numerous interacting spoilage agents which 
may be broadly described as biological, chemical, physical, macro-environ-
mental and micro-environmental (see Figure 3). However, the relative impact 
of these agents will often be determined largely by the nature and extent of 
human intervention as described by the Socio-Economic System (seep. 21 ). 
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THE SPOILAGE SYSTEM 
Figure 3 The Spoilage System 
The factors which primarily contribute to biodeterioration (including 
mould growth) within an ecosystem are: moisture, temperature and pests. 
Moulds can grow over a wide range of temperatures and, in general, the rate 
of mould growth will decrease with decreasing temperature and available 
water. In grains, moulds utilize inter-granular water vapour, the concentration 
of which is determined by the state of the equilibrium between free water 
within the grain (the grain moisture content) and water in the vapour phase 
immediately surrounding the granular particle. The inter-granular water con-
centration is described either in terms of the equilibrium relative humidity 
(ERH, %) or water activity (aw)· The water activity describes the ratio of the 
vapour pressure of water in the grain to the vapour pressure of pure water at 
the same temperature and pressure; the ERH is equivalent to the water 
activity expressed as a percentage. For a given moisture content, different 
grains offer a variety of water activities and consequently support differing 
rates and type of mould growth. Typical water activities necessary for mould 
growth range from 0.70 to 0.99. 
The interaction between grain temperature and moisture content also 
affects the extent of mould colonization. The passage of water from the grain 
into the vapour phase is encouraged by an increase in temperature. 
Consequently, for a given moisture content, the water activity and the pro-
pensity for mould growth will increase with temperature. Maize, for example, 
can be relatively safely stored for one year at a moisture level of 15% and a 
temperature of 15 °C; however, the sarne maize stored at 30 oc will be sub-
stantially damaged by moulds within three months. 
Insects and mites (arthropods) can also contribute significantly to the bio-
deterioration of grain through the physical damage and nutrient losses caused 
by their activities, and their complex interaction with moulds and mycotox-
ins. In general, insects do not infest grain below 17 oc, but mite infestations 
can occur between 3 and 30 oc and above 12% moisture content. The meta-
bolic activity of insects and mites increases both moisture content and tem-
perature of the infested grain. Arthropods also act as carriers of mould 
spores, and their faecal material can be utilized as a food source by moulds. 
Moulds can provide food for insects and mites although in some cases, they 
may also act as pathogens. 
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Another important factor which can affect mould growth is the proportion 
of broken kernels in a consignment of grain. Broken kernels, caused by gen-
eral handling and/or insect damage, predispose the exposed endosperm to 
mould invasion. lt has been estimated that increasing the proportion of 
broken grains by 5% will reduce the storage-life of that consignment by 
approximately one order of magnitude, i.e., from perhaps 150 to 15 days 
(Steel et al., 1969). 
Mould growth is regulated by the proportions of oxygen, nitrogen and car-
bon dioxide in the inter-granular atmosphere. Many moulds will grow at very 
low oxygen concentrations; linear growth, for example, will be halved only if 
the oxygen content is reduced to less than 0.14%. Interactions between the 
gases and the prevailing water activity also influence mould growth. 
The interactions described above, within granular ecosystems, will support 
the growth of a succession of micro-organisms, including toxigenic moulds, 
as the nutrient availability and micro-environment changes with time. In the 
field, grains are predominantly contaminated by those moulds requiring high 
water activities (at least 0.88) for growth, whereas stored grains will support 
moulds which grow at lower moisture levels. 
Any activity which disturbs the stability of an ecosystem will increase the 
production of secondary metabolites, including mycotoxins. Such activities 
include the widespread use of fertilizers and pesticides, high-yielding plant 
varieties, and the cultivation of a limited number of plant species with restric-
ted genetic variation. The normal practices of harvesting, drying, storage and 
processing also, of course, significantly disturb those ecosystems which have 
been established before harvest. 
lt is well recognized that water activity and temperature are the main fac-
tors influencing the production of mycotoxins. However, given the complex-
ity of the ecosystems supporting the production of mycotoxins, the conditions 
under which toxigenic moulds produce mycotoxins are still poorly defined; 
they have recently been comprehensively reviewed (International 
Commission on Microbiological Specifications for Foods, 1996). 
THE MYCOTOXIN SYSTEM 
The Mycotoxin System (see Figure 4) may be considered in terms of four 
interacting subsystems: toxicology, metabolism, health and productivity, and 
wealth. Following exposure (by ingestion, inhalation or skin contact), the 
toxicity of a mycotoxin is determined by a sequence of events (metabolism) 
involving the administration, absorption, transformation, pharmacokinetics, 
molecular interactions, distribution, and excretion of the toxin and its metab-
olites. In turn, the toxicity of a mycotoxin will be manifested by its effect on 
the health and productivity of crops, humans and animals; these effects will 
influence the production of wealth associated with human endeavour and 
agricultural and livestock products. 
The Mycotoxin System may be used as a conceptual model for a dis-
cussion of: (a) mycotoxins of world-wide importance; (b) mycotoxins of 
regional importance; and (c) mycotoxins of possible importance. 
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THE MYCOTOXIN SYSTEM 
Figure 4 The Mycotoxin System 
Mycotoxins of world-wide importance 
Table 1 and Figure 5 show those moulds and mycotoxins currently con-
sidered to be of world-wide importance (Miller, 1994). 
An 'important' mycotoxin will have demonstrated its capacity to have a 
significant economic impact on the exposed population. The frequency and 
level of occurrence are obviously major factors when considering the 
'importance' of a mycotoxin. A mycotoxin which is highly toxic, but which 
occurs only in isolated regions, should be considered as 'important' if the 
mycotoxicosis clearly associated with the toxin has a significant economic 
impact within the affected region. 
Table 1 Moulds and mycotoxins of world-wide importance 
Mould species 
Aspergillus parasiticus 
A. flavus 
Fusarium sporotrichioides 
F. graminearum 
F. moni/iforme 
Penicillium verrucosum 
A. ochraceus 
The aflatoxins 
Mycotoxins produced 
Aflatoxins B1, B2, G,, G2 
Aflatoxins B1, B2 
T-2 toxin 
deoxynivalenol (or nivalenol in some areas) 
zearalenone 
fumonisin B1 
ochratoxin A 
The optimal water activity for growth of A. flavus is high (about 0.99). The 
maximum is at least 0.998 but the minimum is still ill-defined; Pitt and 
Miscamble (1995) report a minimum of approximately 0.82. Data on the 
effect of water activity on the production of the aflatoxins 81 and 82 are 
inconsistent. In general, production of toxins appears to be favoured by high 
water activity. A. flavus is reported to grow within a temperature range of 
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10-43 °C; optimal growth occurs at a little above 30 oc, reaching as much 
as 25 mm/day. The aflatoxins are produced by A flavus over a temperature 
range of at least 15-37 oc; it is not possible to specify an optimum tempera-
ture, although production between 20 and 30 oc is reported to be signifi-
cantly greater than at higher and lower temperatures. 
The effect of water activity and temperature on the behaviour of A parasi-
ticus is similar to that described for A flavus. Pitt and Miscamble (1995) have 
reported a minimum water activity for growth of about 0.83 and a minimum 
for aflatoxin production of about 0.87. Data on the effects of temperature on 
growth of A parasiticus and the production of the aflatoxins are limited. 
Optimal growth and toxin production reportedly occur at approximately 30 
and 28 °C, respectively. 
The term 'aflatoxins' was coined in the early 1960s when the deaths of 
thousands of turkeys ('Turkey X' disease), ducklings and other domestic ani-
mals were attributed to the presence of A flavus toxins in groundnut meal 
imported from South America (Austwick, 1978). (Although the aflatoxins are 
the major toxins associated with this mycotoxicosis, another mycotoxin, 
cyclopiazonic acid (see Figure 6), has been implicated in the aetiology of 
Turkey X disease (Bradburn et al., 1994).) The chronic effects of low dietary 
levels (parts per billion) of aflatoxin on livestock are also well documented 
and include decreased productivity and increased suceptibility to disease 
(Council for Agricultural Science and Technology, 1989). 
21 
20 
16 
Cyclopiazonic acid 
Figure 6 Cyclopiazonic acid 
The aflatoxin-producing moulds occur widely in sub-tropical and tropical 
climates throughout the world. The aflatoxins may be produced on many 
foods and feeds, especially oilseeds, edible nuts and cereals, both before and 
after harvest (Coker, 1979). 
Aflatoxin B1 is a human carcinogen (IARC, 1993a) and one of the most 
potent hepatocarcinogens known. Human fatalities have also occurred from 
acute aflatoxin poisoning; in India, for example, unseasonal rains and a scar-
city of food in 1974 prompted the consumption of heavily contaminated 
maize (Krishnamachari et al., 1975). If the immunosuppression shown in live-
stock is similarly manifested in humans, it is possible that the aflatoxins (and 
other mycotoxins) could play a significant role in the aetiology of human dis-
ease in developing countries where high levels of exposure have been 
reported. 
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Lubulwa and Davis (1994) studied the economic losses in South-East Asian 
countries (Thailand, Indonesia and the Philippines) attributable to the occur-
rence of aflatoxin alone in maize and groundnuts. They found that about 
66% of the total loss could be attributed to contaminated maize, and that 
spoilage and the deleterious effects on human and animal health accounted 
for 24, 60 and 16% of the total loss, respectively. However, the study only 
considered losses associated with morbidity and premature death due to can-
cer, and it is likely that when the additional effects on human health caused 
by the immunotoxic effect of aflatoxin (and other mycotoxins) are included, 
the percentage loss associated with the human sector is significantly higher. 
The trichothecenes 
Surprisingly little is known about the effects of water activity and temperature 
on the behaviour of the Fusarium moulds and the production of mycotoxins. 
The temperature limits for growth of F. graminearum have not been 
reported, although the optimal temperature has been estimated at 24-26 oc. 
The minimum water activity for growth is 0.9 and the maximum recorded 
limit is more than 0.99. No information is available on the effect of water 
activity and temperature on the production of deoxynivalenol, nivalenol and 
zearalenone. 
The minimum water activity for the growth of F. moniliforme is 0.87 and, 
again, the maximum limit exceeds 0.99. The minimum, optimal and maxi-
mum temperatures for growth are 2.5-5.0, 22.5-27.5 and 32-37 oc, respect-
ively. There is no information on the conditions required for the production 
of fumonisin B1. 
The minimum water activity for the growth of F. sporotrichioides is 0.88 
and the maximum limit greater than 0.99. The minimum, optimal and maxi-
mum temperatures for growth are -2.0, 22.5-27.5 and 35 oc, respectively. 
As with the other Fusarium moulds, there is no information on the conditions 
required for the production of T-2 toxin. 
T-2 toxin and deoxynivalenol (see Figure 5) belong to a large group of 
structurally-related sesquiterpenes known as the 'trichothecenes'. T-2 toxin is 
produced on cereals in many parts of the world and is associated particularly 
with prolonged wet weather at harvest. lt is the probable cause of 'alimentary 
toxic aleukia' (ATA), a disease which affected thousands of people in Siberia 
during the Second World War and led to the elimination of entire villages 
(IARC, 1993b). The symptoms of ATA include fever, vomiting, acute inflam-
mation of the alimentary tract and a variety of blood abnormalities. T-2 toxin 
is responsible for outbreaks of haemorrhagic disease in animals and is associ-
ated with the formation of oral lesions and neurotoxic effects in poultry. The 
most significant effect of T-2 toxin (and other trichothecenes) is the immuno-
suppressive activity which has been clearly demonstrated in experimental 
animals; this activity is probably linked to the inhibitory effect on the bio-
synthesis of macromolecules. There is limited evidence that T-2 toxin may be 
carcinogenic in experimental animals. 
Deoxynivalenol (DON) is probably the most widely occurring Fusarium 
mycotoxin, contaminating a variety of cereals, especially maize and wheat. 
Low concentrations of DON are commonly found in grains in North 
America, Japan and Europe; higher levels may occur intermittently in some 
developing countries. The outbreaks of emetic (and feed refusal) syndromes 
amongst livestock, caused by the presence of DON in feeds, has resulted in 
the trivial name of vomitoxin. 
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The ingestion of DON has caused outbreaks of acute human mycotoxi-
coses in India, China and rural Japan (Luo, 1988; Bhat et al., 1989; IARC, 
1993c). The Chinese outbreak in 1984-85 was caused by mouldy maize and 
wheat; symptoms occurred within 5 to 30 min. and included nausea, vomit-
ing, abdominal pain, diarrhoea, dizziness and headache. 
To date, nivalenol-producing isolates of F. graminearum have only been 
observed on rice and other cereals in Japan and have been associated with 
the occurrence of red mould disease ('Akakabi-byo'). Symptoms include 
anorexia, nausea, vomiting, headache, abdominal pain, diarrhoea and con-
vulsions (Marasas et al., 1984). 
Zearalenone 
Zearalenone is a widely distributed oestrogenic mycotoxin occurring in low 
concentrations, mainly in maize, in North America, Japan and Europe 
(Paucod, 1990). However, high concentrations can occur in developing 
countries, especially when maize is grown under more temperate conditions 
in, for example, highland regions. 
Zearalenone is eo-produced with DON by F. graminearum and has been 
implicated, with DON, in outbreaks of acute human mycotoxicoses. 
Exposure to zearalenone-contaminated maize has caused hyperoestrogen-
ism in livestock, especially pigs, characterized by vulvar and mammary swel-
ling and infertility (Udagawa, 1988). There is limited evidence for the 
carcinogenicity of zearalenone in experimental animals. 
The fumonisins 
The fumonisins are a group of recently characterized mycotoxins produced 
by F. moniliforme; this mould occurs throughout the world and is frequently 
found in maize (IARC, 1993d). Fumonisin B1 has been reported in maize 
(and maize products) from a variety of agroclimatic regions including the US, 
Canada, Brazil, South Africa, Austria, Italy and France. The toxins occur par-
ticularly when maize is grown under warm, dry conditions. 
Exposure to fumonisin B1 (FB 1) in maize causes leukoencephalomalacia 
(LEM) in horses and pulmonary oedema in pigs. LEM has been reported in 
many countries including the US, Argentina, Brazil, Egypt, South Africa and 
China. FB 1 is also toxic to the central nervous system, liver, pancreas, kidney 
and lung in a number of animal species. 
The presence of the fumonisins in maize has been linked with human 
oesophageal cancer in the Transkei, southern Africa and China. The relation-
ship between exposure to F. moniliforme in home-grown maize and the inci-
dence of oesophageal cancer was studied in the Transkei from 1976 to 1986 
(Rheeder et al., 1992). In the high risk cancer area, the percentage of kernels 
infected with F. moniliforme was significantly greater throughout the entire 
study period, and FB 1 and FB2 occurred at significantly higher levels in 
mouldy maize obtained from these areas in 1986. 
There is sufficient evidence in experimental animals for the carcinogeni-
city of cultures of F. moniliforme containing significant amounts of the fumo-
nisins. However, the evidence for the carcinogenicity of fumonisin B1 is 
limited (IARC, 1993d). 
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Ochratoxin A 
A. ochraceus grows more slowly than either A. flavus or A. parasiticus, but it 
can grow at a water activity as low as 0.79. Growth has been reported within 
a temperature range of 8 to 37 oc, with an optimum of 25-31 oc. 
Ochratoxin A is produced within the temperature range 15-37 oc, with opti-
mal production at 25-28 ac. 
P. verrucosum grows within the temperature range 0-31 oc and at a mini-
mum water activity of 0.79. Ochratoxin A is produced over the whole tem-
perature range. Significant quantities of toxin can be produced at a 
temperature as low as 4 ac and at a water activity as low as 0.86. 
Exposure to ochratoxin A (OA) seems to occur mainly in wheat and barley 
growing areas in temperate zones of the northern hemisphere (IARC, 1993e). 
The levels reported range from trace amounts to 6000 11g/kg in Canadian 
wheat. In the UK, levels of 5000 and 2700 11g/kg have been reported in bar-
ley and wheat, respectively. OA also occurs in maize, rice, peas, beans and 
cowpeas; developing country origins include Brazil, Chile, Egypt, Senegal, 
Tunisia, India and Indonesia. 
The ability of OA to transfer from animal feeds to animal products has 
been demonstrated by its presence in Europe in pig blood and retail pork 
products. 
lt has been suggested that pork products are significant human dietary 
sources of OA; it has been found in blood (and milk) from individuals in a 
variety of European countries, including France, Italy, Germany, Denmark, 
Sweden, Poland, the former Yugoslavia and Bulgaria (IARC, 1993e). One of 
the highest reported levels is 100 ng/ml OA in blood from the former 
Yugoslavia (Fuchs et al., 1991 ); 6.6 ng/ml OA has been recorded in milk in 
Italy (Micco et al., 1991 ). 
There are existing or proposed regulations for OA in at least 11 countries; 
the permitted levels range from 1 to 50 11g/kg in foods, and from 100 to 
1000 11g/kg in feeds. In Denmark, the acceptability of pork products from a 
specific carcass is determined by analysing the OA content of the kidney; 
meat and certain organs can be consumed if the OA content of the kidney is 
no more than 25 and 1 0 11g/kg, respectively (van Egmond, 1991 ). 
A provisional tolerable weekly intake of OA of 112 ng/kg body weight has 
been recommended by a WHO/FAO Joint Expert Committee on Food 
Additives (WHO, 1991 ). 
Ochratoxin A has been linked to the human disease Balkan endemic 
nephropathy, a fatal, chronic renal disease occurring in limited areas of 
Bulgaria, the former Yugoslavia and Romania. OA causes renal toxicity, 
nephropathy and immunosuppression in several animal species, and is car-
cinogenic in experimental animals. 
The eo-occurrence of mycotoxins 
The complex ecology of mould growth and mycotoxin production can pro-
duce mixtures of mycotoxins in foods and feeds, especially in cereals. The 
eo-occurrence of mycotoxins can affect both the level of mycotoxin pro-
duction and the toxicity of the contaminated material (Miller, 1991 ). The pro-
duction of aflatoxins in stored grains, for example, may be enhanced by the 
presence of trichothecenes, whereas the toxicology of naturally occurring 
combinations of trichothecene mycotoxins is reportedly determined by syner-
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g1st1c interactions in experimental animals (Schiefer et al., 1986; 
Bhavanishankar et al., 1988). In a study with swine, the effect of DON on 
weight gain and feed conversion was synergized by T-2 toxin. Interactions 
involving non-toxic fungal metabolites have also been reported, including 
the potent synergism of non-toxic F. graminearum metabolites (culmorin, 
dihydroxycalonectrin and sambucinol) with DON (Dowd, 1989). Too little is 
currently known about this particularly important area of mycotoxicology. 
Although the moulds and mycotoxins listed in Table 1 are undoubtedly of 
world-wide importance, they reflect the mycotoxin problem as perceived, 
primarily, within the agricultural and livestock sector in the developed world, 
especially North America. Here, the widespread application of intensive 
farming practices tends to amplify the effects of mycotoxin exposure which, 
in turn, leads to the initiation of comprehensive studies on the occurrence 
and toxicity of the mycotoxin(s) in question. For example, although aflatoxin 
81 (see Figure 5) is now recognized as a potent human carcinogen, interest 
in it was actually initiated in the early 1960s because of its severe impact on 
the poultry industry in the UK. Similarly, studies on DON began in Canada 
in 1980 when substantial levels of the toxin were found in Ontario soft wheat 
and Quebec hard wheat. The major problem faced by the North American 
livestock industry is poor performance arising from low level consumption of 
DON, T-2 toxin and nivalenol. 
Typically, once a livestock-related mycotoxicosis has been identified in 
the developed world, the acquisition of further toxicological data and the 
development of improved analytical methods mean that studies can be car-
ried out on the effect of the toxin on human health in both developed and 
developing countries. For example, during the late 1980s, the ingestion of 
DON was implicated in outbreaks of acute human mycotoxicoses in India, 
China and Japan (Luo, 1988; !ARC, 1989; Bhat et al., 1989). However, this 
scenario m i I itates against the identification and study of mycotoxi ns 
associated primarily with the developing world. 
Mycotoxins of regional importance 
Several mycotoxicoses which are not listed in Table 1 are of importance to 
the exposed populations in the affected regions. The mycotoxicoses in this 
category (see Table 2) include those associated with moulds occurring in 
both growing and stored forage crops. The moulds and mycotoxins include 
those which have been associated with a variety of livestock diseases such as 
ergotism, paspalum staggers, ryegrass staggers, facial eczema, fescue foot, 
lupinosis, slobber syndrome and stachybotryotoxicosis (see Figure 7) (Lacey, 
1 991). 
Most farm animals consume pasture crops either by grazing on the living 
pasture or by eating hay or silage. The crops can be colonized by moulds 
throughout this period, the development of the moulds and the production of 
fungi being dependent on the prevailing ecosystem. Growing crops provide a 
variety of micro-environments. For example, the uppermost leaves of a plant 
will be subjected to extreme fluctuations of temperature and relative humid-
ity, whereas those leaves towards the base will present a more shaded, mod-
erate, humid environment; the surface texture of the leaf will also affect the 
m i cro-envi ran ment. 
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Table 2 Moulds and mycotoxins of regional importance 
Mould species 
Claviceps purpurea 
C. fusiformis 
C. paspali 
Acremonium /oliae 
Balansia spp.? 
Pithomyces chartarum 
Phomopsis leptostromiformis 
Rhizoctonia legumicola 
Stachybotrys atra 
Diplodia maydis 
Mycotoxins produced 
Ergotamine alkaloids 
Clavine alkaloids 
Paspalinine 
Lolitrem 
Alkaloids? 
Sporidesmin 
Phomopsin 
Slaframine 
Satratoxins 
Diplodiatoxin 
Ergotism and Paspalum staggers 
Mycotoxicosis 
Ergotism 
Ergotism 
Paspalum staggers 
Ryegrass staggers 
Fescue foot 
Facial eczema 
Lupinosis 
Slobber syndrome 
Stachybotryotox i cos is 
Diplodiosis 
A wide range of grasses and small-grain plants (especially rye and barley) are 
infected during flowering with ascospores of the genus Claviceps. After infec-
tion, the ovary is replaced by a whitish mycelial mass which produces coni-
dia within a sweet, sticky liquid (honeydew); this, in turn, may be transferred 
by insects, rain-splash and grazing animals to other plants. Eventually, the 
mycelial mass hardens into a seed-like sclerotium (the ergot) which can ger-
minate in the soil, eventually producing ascospores to repeat the infection 
process. C. purpurea and C. paspali are the species most often reported as 
the causes of animal disease, particularly in the southern US, South America, 
southern Africa, Australia and New Zealand. Generally, C. paspali occurs in 
warmer climates than C. purpurea. 
Ergotism 
Moisture is an important factor in the aetiology of ergotism, influencing the 
germination of the C. purpurea sclerotia, the dispersal of the ascospores and 
the infection of the plant. Germination of the sclerotia is enhanced by damp 
conditions, whereas rain or heavy dew will promote the explosive discharge 
of ascospores. Dew accumulated at the base of the style will enhance the 
infection of the plant by encouraging the ascospores to germinate and pen-
etrate the ovary. The presence of ryegrass (Lolium perenne) can significantly 
increase the infection of neighbouring wheat crops, and increasing use of fer-
tilizers is reported to enhance the production of sclerotia. 
Although the careful grading of grains has largely eliminated ergotism as a 
human disease, it is still a significant, sporadic animal mycotoxicosis. The 
main alkaloids produced by C. purpurea are reported to be ergotamine, 
ergostine, ergocristine, ergocryptine and ergocornine. However, the toxins 
produced by specific sclerotia have only rarely been recorded and may well 
depend on the fungal isolate, the host plant and presumably, both the macro-
and micro-environments. 
Ergotism occurs in three forms: a gangrenous form, a convulsive form, and 
a form associated with gastro-intestinal disorders. The gangrenous form of 
ergotism was a major human disease in mediaeval Europe and resulted from 
the consumption of ergot-contaminated rye grain. Early symptoms include 
swollen limbs with a simultaneous burning sensation (St Anthony's Fire), fol-
lowed by necrosis and finally, the loss of appendages. In the 20th century, 
outbreaks of ergotism have occurred in Russia (1926), Ireland (1929), France 
(1953), India (1975) and Ethiopia (1978) (Beardall and Miller, 1994). The 
Indian outbreak was attributed to the consumption of pearl millet 
(Pennisetum typhoideum) infected with C. fusiformis (Krishnamachari and 
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Bhat, 1976). The mycotoxic alkaloids produced by C. fusiformis belong to 
the clavine group (e.g. agroclavine, elymoclavine, chanoclavine, pennicla-
vine and setoclavine) which cause gastro-intestinal disorders (nausea, vomit-
ing, diarrhoea, giddiness and somnolence) rather than the gangrenous and 
convulsive symptoms caused by ergotamines (the primary C. purpurea alka-
loids). 
Both the gangrenous and convulsive forms of ergotism occur in animals; 
the gangrenous form particularly affects the ears, tails and feet whereas the 
convulsive form causes ataxia, convulsions and paralysis. Productivity can 
also be affected and result, for example, in reductions in weight gain, milk 
production and reproductive efficiency. In the US, ergotism is primarily 
associated with the mid/northwestern states. 
Paspalum staggers 
Paspalum staggers, caused by C. paspali, occurs only as a nervous and con-
vulsive disorder which closely resembles ryegrass staggers. The neurotoxic 
metabolites believed to be responsible for the symptoms are paspalinine and 
its derivatives, known collectively as the paspalitrems (Lacey, 1991 ). 
Ryegrass staggers 
Perennial ryegrass (Lolium perenne) staggers is a neuro-muscular disorder 
caused by the lolitrem-producing mould Acremonium /alii; it mainly affects 
sheep and cattle in New Zealand. (lt should not be confused with annual rye-
grass toxicity caused by infection of pasture with a nematode and bacterium.) 
In New Zealand, perennial ryegrass staggers occurs primarily during the 
warm, dry periods of summer and autumn when animals graze to the base of 
pastures, ingesting lolitrem-rich tissue. In sheep, the first symptoms are trem-
bling followed by staggering and finally, collapse. Recovery is rapid, the 
main losses resulting from disorientated animals falling over cliffs or into 
water courses. 
Fescue toxicity and fescue foot 
The perennial grass, tall fescue (Festuca arundinacea), is associated with both 
fescue toxicity and fescue foot. In the US, it is grown on approximately 40 
million acres and accommodates about 22% of the nation's cattle. Annual 
losses in excess of US$ 800 million have been attributed to reduced calving 
rate and reduced body weight of weaned calves caused by fescue toxicity. A 
minority of the herd may also suffer from fescue foot which is characterized 
by dry gangrene in the back legs and sloughing of the hooves. 
lt is not clear which moulds and mycotoxins cause fescue toxicity, 
although alkaloid-producing Balansia spp. have been linked to fescue foot. 
Facial eczema 
Facial eczema, which affects mainly sheep, is the most frequently reported 
form of mycotoxic photosensitization; it is caused by the accumulation of 
phylloerythrin (a porphyrin pigment) as a consequence of mycotoxic liver 
damage. lt is mainly associated with New Zealand but also occurs in 
Australia, South Africa and South America. The causal fungus, Pithomyces 
chartarum, occurs widely in the tropics and has also been reported in the UK 
and US. In New Zealand, the litter from ryegrass/white clover pastures is the 
main substrate for fungal growth, with optimal development occurring at 24-
26 oc. 
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The mycotoxic liver damage associated with facial eczema is caused by 
the sporidesmin mycotoxins, primarily sporidesmin A which is produced in 
greatest abundance at about 20 oc. On highly toxic pastures, sheep can 
develop liver damage after only 3 h of grazing, with severe liver damage 
occurring after 48 h and photosensitivity after 96 h. Although the severity of 
the disease varies from year to year, annual losses can amount to NZ$ 100 
million. 
Geeldikkop is a similar photosensitization disease of sheep occurring in 
the South Africa Karoo; it is associated with the consumption of P. char-
tarum-infected Tribulus terrestris, an annual pasture which grows widely in 
semi-arid regions. it has been reported that T. terrestris enhances the toxicity 
of sporidesmin. 
Lupinosis 
Lupinosis is a hepatoxicosis of sheep, cattle and other animals caused by the 
ingestion of forage crops of Lupinus spp. infected with the mould Phomopsis 
leptostromiformis. Phomopsin A is the major mycotoxin. P. leptostromiformis 
can remain viable in infected seed for at least two years. The spores are pri-
marily dispersed by rain-splash over short distances, and probably by ascos-
pores over longer distances, following rain or heavy dew. The disease is most 
common in sheep in Australia, New Zealand and South Africa; it has not 
been widely reported in the US. Outbreaks in Western Australia often occur 
one to two weeks after cyclonic rainfall of at least 50 mm over three days. 
Slobber syndrome 
Slobber syndrome is characterized by excessive salivation and decreased lac-
tation in horses and cattle. lt is caused by the consumption of red clover 
(Trifolium pratense) hay, occasionally by grazing the growing crop, or by the 
consumption of silage. Other clinical signs associated with the disease 
include diarrhoea, increased lachrymation, feed refusal and in severe cases, 
respiratory failure. it is caused by Rhizoctonia legumicola which produces 
the parasympathomimetic alkaloid, slafrarnine. The liver metabolite of slafra-
mine (a ketoimine) has an affinity for muscarinic receptors of the nervous sys-
tem, and slaframine has a particularly high affinity for receptors in the gastro-
intestinal tract. R. /egumico/a does not produce spores but spreads rapidly 
when the relative humidity is high and the temperature is in the range 25 to 
29 oc. 
Slobber syndrome has caused serious economic losses in the Midwest of 
the US and has resulted in a drastic reduction in the use of red clover as a 
forage crop. 
Stachybotryotoxicosis 
Stachybotryotoxicosis affects mainly horses in eastern Europe following 
exposure to straw and hay infected with the mould Stachybotrys atra. 5. astra 
was first isolated from wallpaper in Prague over 150 years ago. Its toxic metab-
olites include the rnacrocyclic trichothecenes verrucarin J and roridin E, and 
the satratoxins F, G and H. The satratoxins G and H have been identified in 
isolates of 5. atra from Hungary, the former Czechoslovakia and Finland. 
Although the disease affects mainly horses, it has also been reported in 
cattle, sheep, pigs, poultry and man (as a result of inhaling airborne spores). 
In acute cases, animals given contaminated straw for one to two weeks may 
die within a few days. The more typical chronic form is characterized by 
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necrosis of the mucous membranes in the mouth leading to inflammation of 
the whole head and, finally, internal haemorrhage. Stachybotryotoxicosis also 
occurs in the US, and an outbreak in South Africa in 1979 caused high mor-
tality in sheep. 
Oiplodia toxicity 
Diplodia maydis can cause extensive spoilage of maize cobs during wet periods 
in the late growing season in parts of southern Africa. In these regions, diplodio-
sis (a neurotoxicosis) is often the most common bovine mycotoxicosis, the 
symptoms progressing from inco-ordination to paralysis and death. Although 
toxigenic isolates of D. maydis have been identified in South Africa, the US and 
South America, field outbreaks of the toxicosis appear to be restricted to south-
ern Africa. Diplodiatoxin is the only metabolite which has been isolated from 
D. maydis, but it is not considered to be the major neurotoxin. 
Mycotoxins of possible importance 
lt is probable that a number of mycotoxins (known and unknown) produced 
by commonly occurring moulds are 'waiting in the wings' to become 
'important' (see Table 3 and Figure 8). 
Penicillium toxins 
The Penicillium mycotoxins citreoviridin and penitrem A may fall into this cat-
egory. Citreoviridin is produced by P. citreonigrum (synonyms P. citreoviride 
and P. toxicarium); in Japan, it is reported to be responsible for acute cardiac 
beri beri caused by the consumption of mouldy 'yellow rice'(Ueno and Ueno, 
1972). P. citreonigrum is widely distributed and occurs on rice after harvest, 
particularly in the more temperate rice-growing areas when the moisture con-
tent reaches 14.6%. Although a ban on the sale of yellow rice imposed in 
Japan in 1910 resulted in the disappearance of the disease, it is difficult to 
imagine that the toxin (or a related compound) is not being produced, and 
consumed, in other climatic zones similar to those which prevail in Japan. 
Table 3 Mycotoxins of possible importance 
Mould species 
Penicillium citreonigrum 
P. crustosum 
Fusarium spp. (in fruit and 
vegetables) 
Alternaria spp. (in fruit and 
vegetables) 
Mycotoxins produced 
Citreoviridin 
Penitrem A 
Fusarium toxins 
Alternaria toxins 
Mycotoxicosis 
Acute cardiac beri beri 
Neurotoxicosis 
Penitrem A.is produced mainly by P. crustosum which occurs with a high 
frequency in foods and feeds; Pitt and Hocking (1985) isolated it from most 
of the cereal and animal feed samples they examined over a period of more 
than 10 years. The minimum, optimum and maximum temperatures for toxin 
production are less than 17, 20-26 and 30 ac, respectively, and the corre-
sponding water activities are 0.92, 0.995 and 0.999. Penitrem A is a potent 
tremorgenic neurotoxin which has been associated with death and severe 
brain damage in sheep, cows, horses and dogs. The precise role of this 
mycotoxin and other fungal neurotoxins in human and livestock disease has 
yet to be determined. 
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Alternaria and Fusarium toxins in fruit and vegetables 
The role of fruit and vegetables as sources of mycotoxins has not been prop-
erly studied. Although potentially toxigenic strains of Fusarium (including F. 
graminearum, F. moniliforme, F. equiseti and F. sporotrichioides) have been 
reported in a variety of fruit and vegetables, little or no work has been done 
on them (Bianey, 1991 ). Similarly, the significance of the reported occurrence 
of a variety of Alternaria moulds in fruit and vegetables, and of the effect of 
the Alternaria toxins (including alternariol, altenuene, isoaltenuene, altenuene 
monomethylether, the altertoxins and tenuazonic acid) (see Figure 8) on 
human health, has still to be elucidated (Bianey, 1991 ). 
THE SOCIO-ECONOMIC SYSTEM 
The Socio-Economic System describes those social (e.g. cultural, political) 
and economic (macro- and micro-) factors which exert an important influ-
ence on events within the Mycotoxicology System (see Figures 1 and 9). 
These factors should be thoroughly addressed when attempting to control the 
production of moulds and mycotoxins. In some instances, given the complex-
ity and unpredictability of human behaviour, it can be very difficult to inter-
vene successfully within the Socio-Economic System. However, whenever 
efforts are made to improve the quality of foods and feeds, it should be 
clearly established that there is a need for a better quality product, and that 
any associated increase in the cost of the product can be borne by the com-
munity. 
THE CONTROL SYSTEM 
Process-Quality Management 
The Process-Commodity Matrix 
A single commodity system (e.g. an edible nut system) may be considered in 
terms of numerous interacting processes (agricultural, 'technical' and socio-
economic). Some of these are shown in the left-hand column of the Process-
Commodity Matrix (see Figure 9) which may be considered as a more com-
prehensive version of Figure 2 (The Commodity System). The quality of the 
system will be determined by the combined qualities of the individual pro-
cesses; a single process of poor quality will have a deleterious effect on the 
quality of the complete system. The successful management of the processes 
within a commodity system requires the inputs of an inter-disciplinary com-
modity team where the potential advantages arising from the dynamics of 
the team are realized by fully exploiting the interactions between the skills, 
disciplines and backgrounds of the individual team members. 
However, wherever a variety of commodities is produced within a pro-
cess-commodity matrix (see Figure 9), it is highly likely that (a) the process 
skills (e.g. on-farm storage) can be transferred across commodity systems and 
(b) that the commodity systems themselves are interactive. 
The transfer of process skills across commodity systems requires the estab-
lishment of specialist process teams interacting with the appropriate com-
modity teams. (lt is recognized that specialist process teams will often also 
be inter-disciplinary; the on-farm storage process, for example, requires a var-
iety of disciplines.) 
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The interactive nature of 'adjacent' commodity systems may be illustrated 
by considering the oilseed, edible nuts, cereals and feeds systems specified in 
Figure 9. In the production of groundnuts and maize, it is evident that both 
commodities can be considered in terms of both food and feed systems, and 
that activity within one system will influence events in the other. An increase 
in demand for (and in the price of) animal feed, for example, may encourage 
producers to consign a greater proportion of their maize crops to the feed 
sector, and to utilize more of the groundnut crop for the production of oil 
and cake. In turn, the increase in the availability of groundnut oil may influ-
ence the demand for other edible oils. 
Identification 
of systems 
Monitoring of Identification 
interventions of constraints 
Introduction Identification 
of interventions of interventions 
Figure 10 The Process-Quality Management cycle 
The dynamics of the process-commodity matrix will determine the quality 
of any process, or combination of processes; the same milieu can be exploited 
via the concept of the Process Quality Management (PQM) cycle (see Figure 
1 0) to ensure that quality is maintained as fully as possible throughout the 
matrix. Briefly, this process involves: (a) the identification of the contributing 
systems and the interactions within and between the systems; (b) the identifi-
cation of those cells within the process-commodity matrix which are con-
straining the quality of the systems; (c) the design of appropriate interventions 
which will remove the quality constraints; (d) the introduction of the interven-
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tions; and (c) the monitoring of the effectiveness of the interventions. If necess-
ary, quality management can be further refined by referring to the feedback 
obtained from the monitoring process, and repeating the PQM cycle beginning 
at 'identification of constraints'. (In exceptional circumstances, there may also 
be a need to re-identify the selected systems.) 
The Control System (see Figure 11) illustrates the three main types of inter-
vention which are likely to be introduced for the control of mycotoxins after 
the quality constraints have been clearly identified. The interventions most 
likely to be employed may be considered in terms of three interacting subsys-
tems: (i) prevention; (ii) identification and segregation of contaminated 
material; and (iii) detoxification. 
Identification of quality constraints 
Those factors which are compromising the quality of the commodity sys-
tem(s) under investigation and causing the occurrence of moulds and myco-
toxins (i.e., the quality constraints) can be identified by implementing 
carefully designed surveys. Surveillance studies will provide technical data 
(including data generated by observation, the completion of questionnaires, 
interviews, and the analysis of samples), socio-economic data, and analytical 
data obtained by the monitoring of biological samples (e.g. blood, urine, 
milk) collected from individuals. 
lt is beyond the scope of this Bulletin to describe the constantly evolving 
approaches available for the collection and analysis of surveillance data. 
However, the reader is referred to the numerous pub I ications which address 
this topic, including those associated with participatory rural appraisal (PRA), 
agroecosystems, commodity systems assessment methodology, and a variety 
of 'hard' and 'soft' decision support systems (Checkland, 1990; Conway, 
1990; La Gra, 1990; Chambers, 1993). 
Prevention of contamination 
Preventative measures which militate against the onset of spoilage and, sub-
sequently, the production of moulds and mycotoxins, may be introduced 
throughout the Commodity System. Spoilage may be prevented both before 
and after harvest by manipulating those interacting agents (biological, physi-
cal, chemical, macro- and micro-environmental) of bioterioration which pri-
marily contribute to the Spoilage System (see Figure 3). However, the 
opportunity to manipulate the Spoilage System will vary throughout the 
Commodity System and will be determined by the prevailing climate and the 
resources available. For example, the pre-harvest control of biodeterioration 
is somewhat compromised by man's inability to control the climate! Either 
insufficient or excessive rainfall during critical phases of crop development 
can lead to mould contamination and mycotoxin production. The very sub-
stantial economic losses attributed to mycotoxins on the North American 
continent clearly demonstrate the difficulties associated with the pre-harvest 
prevention of contamination, even in wealthy developed nations. 
After harvest, it is important that the crop is dried to a 'safe' moisture level 
(which will not support the production of moulds and mycotoxins) as quickly 
as possible. The resource-rich farmer in the developed world can achieve this 
through mechanical drying whereas the resource-poor farmer will have to 
depend on an adequate supply of sun and wind, and an absence of rain. 
Similarly, richer communities can control the temperature of stored crops by 
refrigeration, but poorer populations do not have this option. The importance 
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of good storage practices in the prevention of spoilage cannot be over-
emphasized . In rural communities, traditional storage methods are the prod-
uct of decades, or even centuries, of development and are normally ideally 
suited to the prevailing agro-climatic conditions. However, if a community is 
forced to move to a new agro-climatic zone, it may be many years before 
the necessary adjustments can be made to the storage procedures. 
Communities may also be forced to accommodate changes to traditional 
methods if, for example, the materials used to construct the stores become 
less readily available, or if new, high-yielding varieties of the stored com-
modity are introduced; these high-yielding varieties are often more suscep-
tible to insect attack than traditional varieties, a situation which can be 
exacerbated by the introduction of exotic insect pests through trade or aid. 
Attempts have been made to prevent mycotoxin contamination by (a) 
breeding for resistance to moulds and (b) 'biocontrol', involving the introduction 
of atoxigenic strains of fungi. 
Breeding for resistance to moulds 
To date, although much effort has gone into the development of varieties of 
groundnuts and maize which are resistant to A. flavus, none has performed 
effectively under field conditions. 
The breeding of Fusarium-resistant varieties of cereals has met with more 
success. There are two components of Fusarium resistance in wheat and 
maize which can be exploited: (i) resistance to initial penetration; and (ii) 
resistance to the distribution of the pathogen in the host tissue. A third com-
ponent to be considered is the effect of the host-pathogen relationship on 
mycotoxin production and/or degradation. However, it has been estimated 
that it will be 10-20 years before resistant hybrids and cultivars become 
commercially available (Miller, 1995). 
The biocontrol of moulds 
The introduction ('seeding') of agricultural crops with atoxigenic (non-toxin pro-
ducing) strains of A. flavus has been evaluated as a means of reducing the tox-
igenicity of the resident fungal population (Cotty et al., 1994). Atoxigenic strains 
reduce aflatoxin contamination by physically excluding the resident strains and 
competing for the resources required for the production of aflatoxins. The most 
comprehensive field tests to date have been carried out on cotton grown in 
Arizona, US. A significant reduction in the aflatoxin content of the mature crop 
was reported when an atoxigenic strain of A. flavus was seeded, on colonized 
wheat grain, into a field of developing cotton prior to flowering (Cotty et al., 
1994). However, further studies are required on the long-term efficacy and 
safety of biocontrol strategies before they can be accepted for routine use. 
Although prevention is better than cure, and despite the best efforts of the 
agricultural community, mycotoxins will continue to be present in a wide 
range of foods and feeds in the foreseeable future. Consequently, strategies 
are required for the removal of mycotoxins from crops. Two approaches are 
currently available: (a) identification and segregation of contaminated 
material; and (b) detoxification of contaminated feeds (see Figure 11 ). 
Identification and segregation of contaminated material 
The identification and segregation of contaminated material may be pursued 
through quality control and monitoring procedures. 
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Figure 12 A large sack-stack of groundnuts 
lt is evident from Figure 11 that the identification and segregation of con-
taminated material requires efficient methodologies for sampling and analysis. 
Sampling 
Most attempts to develop an effective procedure for the collection of rep-
resentative samples from ·food or feed lots have focused on the aflatoxins, 
since the majority of current regulations are concerned specifically with this 
group. However, the design of effective sampling procedures has been ser-
iously hampered by the highly positively-skewed distribution of the aflatox-
ins, problems with the withdrawal of the samples (e.g. when sampling an 
oilseed cake in sacks), and signif icant difficulties when attempting to collect 
samples from throughout a lot. The problems associated with the sampling of 
large lots of stored material are self-evident (see Figure 12). Wherever possible, 
samples should be collected when the lot is mobile and therefore readily 
accessible. The large lot shown in Figure 12, for example, can only be properly 
sampled when the stack is being constructed or dismantled. Ideally, samples 
should be collected automatically from a moving stream of material. 
Although tremendous progress has been made in the development of ana-
lytical methods for mycotoxins, attempts to develop internationally accepted 
sampling protocols have met with little success. Recently, the Food and 
Agricu lture Organization (FAO) outlined options for sampling plans linked to 
maximum permissible levels (gu idelines) of 5, '10, 15, 20 and 30 j.tg/kg afla-
toxin B1 in maize and groundnuts; but they fell short of a firm and inter-
nationally-binding endorsement (FAO, 1993). 
The mycotoxin contamination of foods and feeds has attracted global 
attention. lt has had a significant impact on the international trade of import-
ant foods and feeds, including those which originate in developing countries. 
Importing nations, frequently in the developed world, protect their popula-
tions from exposure to mycotoxins by introducing legislation which strictly 
limi ts the levels of mycotoxin (particularly aflatoxin) permitted in imported 
products. When adopting such a strategy, importing nations have a responsi-
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Figure 13 A subsampling mill 
bility to ensure that the permitted levels strike a fair balance between what is 
achievable by the producers in practice and the level of protection required 
by the consumers. 
Representative samples of foods and feeds typically weigh between 3 and 
20 kg (Coker, 1989; Coker, 1997) . lt is therefore essential that sample prep-
aration procedures should allow the production of laboratory samples which 
are representative of the original sample. Laboratory samples may be pro-
duced by successively comminuting and dividing the sample, using either 
static or rotary dividers. Ideally, the comminution and sample-division steps 
should be performed simultaneously using a sub-sampling mill. The device 
illustrated in Figure 13 converts large samples of particulate materials into 
comminuted, representative sub-samples in a single operation. 
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Figure 14 A large shipment of animal feed 
Those responsible for the production, processing and marketing of foods and 
feeds need to monitor the quality of the commodity constantly, either by 
implementing a traditional quality assurance programme or, ideally, through 
a Hazard Analysis Critical Control Point (HACCP) System. Again, a variety of 
contamination levels and quantities of materials will need to be addressed 
from, for example, a 50 000 tonne shipment of animal feed (see Figure 14) 
to a 50 g packet of roasted peanuts. Sampling plans will be needed which 
can be applied to a wide variety of situations. Ideally, the critical points 
identified by surveillance as contributing to the spoilage of the commodity 
and to the production of mycotoxins, should be integrated into quality con-
trol schemes and/or regulatory monitoring programmes. 
Figure 15 A 20-tonne batch of groundnuts 
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More than 50 countries currently regulate mycotoxins (especially the afla-
toxins) in foods and feeds. There are usually specific regulations for both 
unprocessed and processed material. In the UK for example, a lot of unpro-
cessed edible peanuts is acceptable if it contains no more than 10 11g/kg of 
total aflatoxins, whereas a retail pack (a small unit of food purchased by the 
consumer) of peanuts must contain no more than 4 llg/kg. In this example, 
attention is focused on a lot of unprocessed peanuts (typically around 20 
tonnes in weight; see Figure 15) and on a small, retail pack (of around 1 OOg) 
of processed nuts. Sampling plans which can be applied to both these situa-
tions are therefore required by the regulators. 
The analysis of mycotoxins 
The method of analysis will be determined by the nature of the job. If a large 
number of samples is to be analysed, an automated procedure such as HPLC, 
HPTLC or ELISA will be advantageous. However, automated methods offering 
high sample throughput, accuracy and precision require the purchase of 
expensive equipment. Such an investment would be justified in a busy qual-
ity control or research laboratory staffed by ski lied analysts. 
However, rapid methods, which are appropriate for the analysis of inter-
mittent samples requiring a quick decision by relatively unskilled operators, 
are also required. Such methods must be simple to perform and must require 
relatively unsophisticated equipment. 
Sample clean-up methods 
The efficiency of chromatographic methods of analysis will be largely deter-
mined by the effectiveness of the sample clean-up step (i.e., the removal of 
interfering components from the initial, crude sample extract). Two recent 
developments have improved the precision of the clean-up procedure and 
facilitated the automation of this step. 
The first development, known as solid phase extraction (SPE), involves the 
use of liquid phases bonded to an inert support, contained within a plastic 
cartridge (Coker and Jones, 1988). SPE utilizing a phenyl bonded-phase is 
used routinely at the Natural Resources Institute (NRI) for the clean-up of 
sample extracts of groundnut, cottonseed, corn, copra and oil-palm prior to 
the quantification of aflatoxin. A small volume of the crude sample extract 
(normally in aqueous acetone) is applied to the SPE cartridge which is then 
washed with water. After drying by the passage of air, the aflatoxins are 
eluted with chloroform and the eluate dried by passing through a sodium sul-
phate cartridge. Liquid handling equipment is now available which facilitates 
the automation of the SPE clean-up procedure. 
After SPE clean-up, quantification may be performed by HPTLC, HPLC or 
another method. 
At NRI, a combination of SPE (phenyl) clean-up and HPTLC quantification 
has been successfully applied to the analysis of aflatoxin in a variety of com-
modities including corn, cottonseed, oil-palm, copra and peanut butter 
(Bradburn et al., 1988; Tomlins et al., 1989; Bradburn et al., 1990; Dell et 
al., 1990; Nawaz et al., 1992; Nagler, personal communication). 
SPE clean-up methods have also been used in conjunction with HPLC 
quantification for the analysis of aflatoxin in groundnuts, cottonseed and corn 
(McKinney, 1981; Hutchins and Hagler, 1983; Hurst et al., 1987; Coker and 
Jones, 1988). 
30 
The second development in improved clean-up methodology is the immuno-
affinity cartridge. In this approach, the crude extract is passed through a car-
tridge containing monoclonal mycotoxin antibodies adsorbed on to an inert 
support. The retained mycotoxins are eluted from the affinity column with 
methanol prior to quantification using a method of choice. Affinity cartridges 
are commercially available for the analysis of the aflatoxins B1 , B2 , G1 , G2 
and M 1, and for the determination of fumonisin B1, OA, DON and zearalenone. 
After immunoaffinity clean-up, quantification may be performed by con-
ventional HPLC methods, or by using a simple fluorometer for example. 
lmmunoaffinity clean-up has been used in conjunction with a simple fluo-
rometer for the analysis of total aflatoxins in corn (Anon., 1990). In this pro-
cedure, the methanolic eluate from the affinity cartridge is treated with 
bromine solution to enhance the fluorescence of the aflatoxins B1 and G1 . 
This method has been adopted by the USDA Federal Grain Inspection 
Service. 
Rapid analysis methods 
The utilization of sophisticated HPLC, HPTLC, GLC, ELISA and mass spectra-
metric procedures has been comprehensively reviewed elsewhere (Coker, 
1984; Shephard, 1986; Coker and jones, 1988; Beaver, 1989; Morgan, 1989; 
Coker et al., 1993). 
Effective quality control protocols require simple, rapid, efficient analysis 
methods which can be handled by relatively unskilled operators. Recently 
developed rapid methods include those which utilize immunochemical tech-
nology (see above) or selective adsorption agents. 
lmmunochemical technology has been applied to the development of 
rapid ELISA methods for a variety of mycotoxins including the aflatoxins, 
OA, fumonisins, zearalenone, T-2 toxin and DON. 
A rapid ELISA method for estimating aflatoxin in groundnuts, cottonseed, 
corn, rice and mixed feeds has been subjected to a collaborative study and 
recommended for First Action Approval by the Association of Official 
Analytical Chemists (AOAC) (Anon., 1989). 
Solid-phase ELISA kits have been developed for estimating aflatoxin, zear-
alenone, OA and T-2 toxin in a variety of commodities. An 'immunodot' cup 
test in which the antibody is immobilized on a disc in the centre of a small 
plastic cup, has been approved by the AOAC as an Official First Action 
screen for aflatoxin in groundnuts, corn and cottonseeds (Trucksess et al., 
1990). 
Card tests have also been developed in which the antibody is immobilized 
within a small indentation on a card similar in size to a credit card. These 
tests have been developed for estimating aflatoxin, zearalenone, OA and T-2 
toxin in corn. 
The reported analysis (extraction, filtration and estimation) time for solid-
phase ELISA kits is about 5-10 min. Doerner and Cole (1989) compared 
rapid ELISA and solid-phase ELISA methods with a conventional HPLC proce-
dure for aflatoxin in groundnuts. There was a good agreement between the 
methods when the aflatoxin concentration of the sample was greater than 
1 Ouglkg. 
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Mini-columns containing selective adsorption agents have been developed 
for aflatoxin/zearalenone (single test) and DON (Cordon and Cordon, 1990). 
In the aflatoxin/zearalenone test, the extracted mycotoxins are partitioned 
into toluene which is added to the mini-column. Selective adsorption agents 
remove interfering compounds and retain the mycotoxins as two discrete 
bands at the lower tip of the column. Designated levels of the mycotoxins 
can be observed under long-wave UV light. 
The Federal Grain Inspection Service (FGIS) has evaluated eight commer-
cially available, rapid tests for aflatoxin in corn. FGIS-approved kits include 
rapid ELISA, immunoaffinity cartridge, solid-phase ELISA and selective 
adsorbent mini-column procedures (Emnett, 1989). 
Accredited methods 
Although a number of procedures for the determination of the aflatoxins 
has been adopted by the AOAC and similar organizations, the only other 
mycotoxins represented by 'official' methods for foods and feeds are DON in 
wheat (two methods), OA in barley and green coffee, zearalenone in corn 
(two methods), patulin in apple juice and sterigmatocystin in barley and 
wheat. Also, the unavoidable delay between the development and validation 
of a new method, and the considerable cost of organizing collaborative 
studies, often result in the use of considerably out-dated 'official' methods. 
Current AOAC methods for the aflatoxins, for example, include procedures 
developed between 1968 and 1989; six of the eight 'official' methods were 
developed before or during 1980. The methods for DON and OA were 
developed in 1986 and 1973, respectively, and the 'official' procedures for 
zearalenone were developed in 1976 (TLC) and 1985 (HPLC). 
This situation militates against the use of state-of-the-art procedures for the 
surveillance, monitoring and quality control of mycotoxins in foods and 
feeds. Given the current trend towards the accreditation of analytical 
methods within individual laboratories, an alternative to the use of 'official' 
methods may be to develop an accredited method which fulfils defined 
efficiency criteria (limit of detection, precision and accuracy) when imple-
mented by an individual laboratory. National laboratories would be respon-
sible for the administration of the proposed method accreditation scheme, 
including the organization of check sample studies to confirm that analytical 
laboratories are meeting the required efficiency criteria. Inter-country harmo-
nization would be of paramount importance. Harmonization within Europe, 
for example, could be pursued through the EC Measurement and Testing 
Programme. 
The concept of utilizing accredited methods for the determination of 
mycotoxins has been endorsed by the EC expert committee, 'Agricultural 
Contaminants'. The use of Certified Reference Materials (CRMs) provided by 
the Community Bureau of Reference (BCR) Measurement and Testing 
Programme for the quality assurance of analytical procedures, has been sup-
ported by the Comite European de Normalisation (CEN). 
A similar approach to method accreditation has already been adopted by 
the AOAC for the validation of immunodiagnostic kits. In 1991, the AOAC 
Research Institute was established to review independently manufacturer-gen-
erated data and laboratory evaluations of test kits. The manufacturers of 
accredited kits are licenced to use the Institute's 'Performance Tested' certifi-
cation mark. 
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The AOAC has recently established a Peer-Verified Methods (PVM) 
Advisory Committee to promote the rapid validation of newly developed 
methods. AOAC members are encouraged to seek PVM status for their 
methods so that more recently developed procedures can be used in con-
junction with the AOAC Official Methods. 
Bioassays 
Even in a well-equipped laboratory, the chemical/immunochemical determi-
nation of mycotoxins will be limited to about 20 compounds; the simul-
taneous analysis of every sample for all possible mycotoxins will be 
prohibitively expensive and time-consuming. In addition, chemical analysis 
will not detect the presence of previously unknown mycotoxins. 
Bioassays for the detection of mycotoxins can be defined as tests on bio-
logical systems designed primarily to confirm the presence of biologically-
active compounds, the identity and concentration of which can be deter-
mined by chemical analysis. 
In the first instance, a bioassay should be non-specific, highly sensitive, 
rapid and robust. Ideally, specific bioassays are also required to assist with 
the identification of the mycotoxin(s) under investigation. 
The development of a bioassay requires the choice of a sensitive biologi-
cal indicator and the establishment of a dose-response relationship which is 
sigmoid in shape but linear over a wide range of doses. The experimental 
protocol should also accommodate variations in species, age, sex, method of 
toxin administration, nutritional and disease status, and environmental fac-
tors, which can influence the effect of mycotoxins on animal species. 
The use of bioassays for the detection of mycotoxins has been reviewed 
by Panigrahi (1993); test organisms include terrestrial and aquatic, animal 
and plant species. 
A bioassay has been developed which exploits the sensitivity of the yeast, 
Kluyveromyces marxianus, to a range of mycotoxins (Dell, 1993; Engler, 
1996). Two approaches have been used. First, measurement of the retardation 
in growth rate has facilitated the detection of a range of mycotoxins using an 
automatic microtitre plate-based procedure for recording the optical density 
of the yeast suspension. The second simple calorimetric approach exploits 
the inhibition of the induction of galactosidase enzyme by toxins. 
lt is clear that a combination of bioassay, chemical and immunochemical 
methods should be used as an integrated approach towards the effective 
determination of mycotoxins in foods and feeds. Such an approach requires a 
battery of bioassays which, given those methods currently available, could 
include plant-based, brine shrimp larvae, Tetrahymena, chick embryo, tissue 
culture and yeast bioassay systems. 
Detoxification 
Numerous oxidizing agents, aldehydes, acids and bases (inorganic and 
organic) have been investigated as potential chemical detoxification agents 
(Park et al., 1988). Patented procedures exist which utilize ammonia, calcium 
hydroxide, hydrogen peroxide, methylamine and a mixture of calcium hydro-
xide and methylamine. Commodities which have been experimentally treated 
in this way include groundnut meal (ammonia, hydrogen peroxide, formal-
dehyde, calcium hydroxide plus methylamine, sodium hydroxide), cottonseed 
meal (ammonia, sodium hydroxide, calcium hydroxide), corn (ammonia, 
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sodium bisulphite, calcium hydroxide), copra (calcium hydroxide) and poul-
try feed (sodium hydroxide). Detoxification equipment has included large 
plastic silage bags (ammonia/corn, cottonseed), pelleters (sodium hydroxide/ 
poultry feed; calcium hydroxide/copra), pressurized reaction vessels 
(ammonia/groundnut and cottonseed meal), unpressurized reaction vessels 
(calcium hydroxide plus formaldehyde/groundnut cake) and screw press 
extruders (calcium hydroxide plus methylamine/groundnut meal). 
Ammonia detoxification 
The chemical detoxification reagent which has attracted the widest interest is 
ammonia, both as an anhydrous vapour and an aqueous solution. 
Consequently, many studies have been performed within the EC and else-
where, on the efficiency of ammonia detoxification and the nutritional and 
toxicological properties of ammoniated feeds. 
Ammonia was first used for the detoxification of aflatoxin-contaminated 
cottonseed meal in the US in the late 1960s (Park et al., 1988). Temporary 
Food and Drug Administraton (FDA) approval was obtained for using ammo-
niated cottonseed meal in feedstuffs for non-lactating ruminants and laying 
hens. However, although numerous nutritional and toxicological studies have 
since been performed under the auspices of the National Cottonseed 
Growers Association, formal FDA approval of the ammoniation process is 
sti 11 awaited. 
Ammoniation has, however, been approved by some states including 
Arizona, California, Georgia, North Carolina and Alabama. Arizona and 
California allow the treatment of cottonseed products, and in Georgia, North 
Carolina and Alabama, corn is ammoniated. 
The procedures used in Arizona are either atmospheric pressure/ambient 
temperature (APAT), or elevated temperature and pressure. The APAT proce-
dure involves spraying cottonseed with aqueous ammonia and storing it for 
approximately two weeks in large, white silage bags. The elevated tempera-
ture/pressure procedure utilizes a large, rotating pressure vessel. Ammonia 
(4% w/w) and steam are added to the cottonseed to produce a pressure of 40 
psi [270 kPa] and a temperature of 100 oc. A dwell-time of 30 min. is used. 
Although the APAT process has not been approved by the Californian auth-
orities, a high temperature/pressure treatment is used which involves 1 .5% 
ammonia, 14% moisture and a pressure of 30 psi [207 kPa]. 
A procedure for the detoxification of corn involves the successive addition 
of water (to 17.5% moisture) and ammonia to 29-tonne batches of corn held 
in special bins (Coker et al., 1985). A mixture of ammonia and air is recycled 
through the corn for 48 h. The treated material is held at a mean temperature 
of approximately 36 oc for a further 11 days. The ammoniated corn is then 
transferred to a drying bin where it is deodorized and dried using hot air to a 
moisture content of about 1 0%. 
Commercial ammoniation plants for the treatment of groundnut meal are 
currently operating in Senegal, France and the UK. 
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The chemistry of ammoniation 
The nature of the reaction products produced by the ammon1at1on of afla-
toxin is still poorly defined. Most studies have focused on the reaction prod-
ucts of aflatoxin B1 produced under a variety of conditions, including the 
treatment of: (a) pure toxin, in vitro; (b) pure toxin on an inert carrier; (c) 
feedstuffs spiked with pure toxin; and (d) naturally contaminated feedstuffs. 
In vitro ammoniation of pure aflatoxin B1 yields four compounds of mol-
ecular weights (MW) 286, 256, 236 and 206, and many unidentified com-
pounds of MW less than 200. The compound of MW 286 has been 
characterized as the decarboxylated derivative (aflatoxin D,) of aflatoxin B,. 
The compound of MW 206 lacks the cyclopentenone ring of aflatoxin D
1
• 
The loss of the methoxy group from aflatoxin D
1 
produces the compound of 
MW 256. The reaction product of MW 236 has yet to be identified (see 
Figure 16). 
When aflatoxin B1 was treated with ammonium hydroxide at 100 ac, 
approximately 30% of the crude reaction product was attributed to aflatoxin 
D1 (Lee et al., 1974). In a similar experiment, the reaction product contained 
between 3 and 26% of compound MW 206, depending on the duration of 
the reaction. An increase in the concentration of this compound was accom-
panied by a decrease in the concentration of aflatoxin D1 (Cucullu et al., 
1976). 
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Figure 16 The in vitro ammoniation of aflatoxin B1 
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When pure radio-labelled aflatoxin B1, on an inert carrier, was treated 
with ammonia at 40 psi [270 kPa] and 100 oc, 20% of the label was lost as 
volatile compounds while less than 1% remained as unreacted aflatoxin B1• 
Although the reaction product of MW 206 was identified, no aflatoxin 0 1 
was detected (Lee et al., 1984). 
Further studies were carried out using groundnut meal spiked with 
labelled aflatoxin B1• Treatment at 75 oc produced an ammoniated product 
which contained only 45-50% of the label. Unreacted aflatoxin B1 and afla-
toxin 0 1 accounted for only 0.3 and 0.2% of the reaction product respect-
ively. Some activity was also detected in the volatile fraction (Lee et al., 
1979). 
Similar, larger scale studies involved the ammoniation of a 28 kg batch of 
naturally contaminated cottonseed meal additionally spiked with labelled 
aflatoxin B1 • Treatment at 40 psi [270 kPa] and 100 oc yielded an ammo-
niated product which accounted for about 86% of the radioactivity; 37% of 
the activity remained in the meal after solvent extraction and chemical and 
enzymic treatments (Park et al., 1984). Subsequent mass spectral analysis of 
the ammoniated product confirmed the absence of both aflatoxin 0 1 and 
compound MW 206 (Lee et al., 1985). However, aflatoxin 0 1 was detected 
by tandem mass spectrometry in very heavily aflatoxin-contaminated corn 
(175 ppm) after ammoniation at 37 oc for 21 days. The yield of aflatoxin 0 1 
was estimated to be substantially less than 10% (Grove et al., 1984). 
Ammoniation and the nutritional quality of feed 
Ammonia will interact with a variety of compounds which determine the 
nutritional quality of feedstuffs. The nature of this interaction will be gov-
erned by the precise conditions of ammoniation and by the composition of 
the feedstuff. lt may be difficult to predict fully the effect of ammoniation on 
compound feeds of variable composition. 
Ammoniation produces changes in protein patterns accompanied by a 
reduction in, for example, the levels of cystine, methionine and available 
lysine. The nitrogen solubility index is also reduced, indicating that some 
degree of thermal/chemical denaturation of protein has occurred (Park et al., 
1988). Residual ammonia increases the level of non-protein nitrogen in 
ammoniated feeds. Although small increases of this nature can be accommo-
dated by ruminants, excessive residual ammonia is highly undesirable in 
monogastric feeds. No significant changes have been reported in the levels 
of starch and lipid components (Peplinski et al., 1983). 
In vitro studies have shown that ammoniation increases amino acid 
digestibility and amyloglucosidase activity ((Adrian, 1976; Brekke et al., 
1978). 
In general, ruminants showed improved weight gains and feed efficiency 
when fed ammoniated diets. Non-ruminants either showed no effect, or suf-
fered a decrease in these parameters. 
Undoubtedly, the attractiveness of ammoniated commodities as animal 
feedstuffs will be determined by the net result of a complexity of interactions. 
Ammoniation and feed toxicity 
The interaction of ammonia with both aflatoxin and the nutritional compo-
nents of feedstuffs has been outlined in the two previous sections. The result-
ant composition of these reaction products will determine the effect of 
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ammoniation on both the nutritional and toxicological properties of the trea-
ted commodity. These properties will, in turn, determine the productivity of 
animals fed ammoniated feeds and the acceptability of animal products 
(milk, meat and eggs) as human food. 
Toxicity of ammoniation reaction products 
The toxicity of the reaction product, aflatoxin D 1, has been compared with 
that of aflatoxin B1 using: (a) the Ames test (Salmonella mutagenicity); (b) the 
DNA covalent binding index (CBI); and (c) the chick embryo bioassay, as 
indicators of toxicity. Aflatoxin D 1 caused a 450-fold decrease in mutagenic 
potential, at least a 300-fold decrease in the DNA CBI (46), and a 20-fold 
decrease in toxicity to the chick embryo (Lee et al., 1981 ). The reaction 
product, MW 206, was more than 600 times less mutagenic than aflatoxin B1 
(Haworth et al., 1989). 
Animal feeding trials 
Very extensive feeding trials with ammoniated feeds have been carried out in 
a variety of animals including trout, rats, poultry, swine and beef and dairy 
cattle. The effect of ammoniation on the toxicity of aflatoxin-contaminated 
feeds has been determined by monitoring animal growth and organ weights, 
and by examining haematological, histopathological and biochemical par-
ameters. 
A 90-day feeding trial in male and female weaning Fischer 344 rats was 
performed using low pressure ammoniated (1.5% ammonia, 10 psi [69 kPa], 
90 °C) groundnut cake (Manson and Neal, 1987). Four diets were prepared, 
each containing 75% groundnut cake and 25% powdered rat diet. Two diets 
(at 600 ppb) contained naturally aflatoxin-contaminated groundnut cake 
while the remaining diets were uncontaminated. One of each of the contami-
nated and uncontaminated diets was ammoniated. (The contaminated diet 
contained 40 ppb aflatoxin after ammoniation.) The hepatotoxic and poten-
tial hepatocarcinogenic effects of the diets were assessed by assaying the 
activity of y-gl utamyl transferase (GGT) in the rat I ivers. The resu Its indicated 
that ammoniation of the aflatoxin-contaminated cake eliminated the develop-
ment of focal GGT-positive (preneoplastic) lesions in both male and female 
animals. However, in the female rat, histochemical GGT staining of periportal 
hepatocytes was increased by all the experimental diets (including the 
ammoniated uncontaminated diet) compared with the untreated, uncontami-
nated diet. Ammoniated diets also decreased body weight gains. 
The toxicity of low pressure ammoniated groundnut cake was also 
assessed by feeding ducklings five diets for 22 days (Coker et al., 1983). The 
diets consisted of a control (zero aflatoxin) and feeds containing 5 and 25% 
ammoniated or untreated aflatoxin-contaminated cake. The ducklings which 
received the diet (300 ppb total aflatoxin) containing 25% untreated cake 
showed very low growth rates; all birds in this group had died by day 14 of 
the trial. No significant difference in growth was apparent between those 
ducklings receiving a control diet (<2.0 ppb aflatoxin) and those receiving 
5% ammoniated cake (5 ppb). The performances of birds fed diets containing 
5% untreated cake (50 ppb) and 25% ammoniated cake (15 ppb) were 
slightly reduced compared to the other groups. (The high natural biological 
variation within each group of ducklings made an accurate assessment of the 
significance of small differences in performance extremely difficult.) 
Microscopic examination showed that there were no abnormal lesions in the 
livers of ducklings which had received a diet containing 5% ammoniated 
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groundnut cake, but five of the nine livers from ducklings fed on the diet 
containing 25% ammoniated groundnut cake showed slight centriacinar bile 
duct proliferation; there was also evidence of single cell necrosis in one liver. 
All nine birds receiving a diet containing 25% untreated cake had marked 
bile duct proliferation, with five of the livers also showing single cell necro-
sis. Of the nine ducklings on 5% untreated cake, the livers of eight showed 
slight bile duct proliferation; the liver of the remaining duckling showed a 
marked proliferation of the bile duct. There was no evidence of centriacinar 
fibrosis in the livers of ducklings which had received diets containing ammo-
niated groundnut cake. 
Rat feeding trials were carried out over a two-year period (Park et al., 1988). 
The diets contained uncontaminated or aflatoxin-contaminated cottonseed 
meal, either ammoniated or untreated, at inclusion rates of 20%. None of the 
male rats on untreated, contaminated diets survived the trial. Female survival 
was also significantly reduced compared to rats fed uncontaminated diets. 
Organ weights in male rats were similar for ail the ammoniated diets and were 
significantly lower than those in rats fed uncontaminated feed. Rats receiving 
either uncontaminated or ammoniated diets did not exhibit liver neoplasms. 
The safety of meat and eggs produced by animals receiving diets contain-
ing ammoniated feeds has been evaluated by the USDA and the FDA (Park 
et al., 1988). Diets containing uncontaminated or aflatoxin-contaminated corn 
(either ammoniated or untreated) were fed to poultry, pigs and beef cattle. 
Meat and eggs from these animals were then fed to rats (as 20% of the diets) 
for a 15-18 month period. No toxic or carcinogenic effects were reported. (A 
reduction in the survival of male rats receiving eggs was attributed to nutri-
tional deficiencies in the diet.) Multi-generation studies on rats have been car-
ried out by the USDA using poultry and beef tissue derived from animals fed 
ammoniated, aflatoxin-contaminated corn (Food and Drug Administration, 
1982). A teratological evaluation indicated that foetal development was not 
affected by the consumption of tissue (as 20% of the diet) derived from poul-
try and cattle fed ammoniated corn for periods of 15-18 months. 
The toxicity of milk derived from dairy cattle fed ammoniated cottonseed 
meal has been evaluated in rainbow trout (Sinnhuber, Ljnpublished material). 
The aflatoxin content of contaminated cottonseed meal (about 4000 ppb, 
total) was reduced to <5.0 ppb aflatoxin by ammoniation. Ingestion of the 
treated meal (about 3.6 kg/cow/day) yielded milk with no detectable afla-
toxin M 1 • The freeze-dried milk was fed to rainbow trout as 25% of the diet 
for 12 months. The low incidence of observed hepatomas was similar to that 
induced by low dietary levels of aflatoxin. 
Ammoniated corn has been fed directly to trout as 25% of the diet 
(Brekke et al., 1977). There was no significant difference in the incidence of 
hepatomas between those fish fed uncontaminated corn and those receiving 
the ammoniated diet. 
Poultry The effect of ammoniated feeds on the productivity, disease resist-
ance and biochemical parameters in poultry has been examined. 
Feeding trials with day-old ducklings, using ammoniated groundnut cake 
produced by a low pressure ammoniation process, are described above. 
Studies with day-old chicks have also been reported elsewhere (Delort-Laval 
et al., 1980). Diets containing ammoniated groundnut cake did not affect 
feed intake, although a slight reduction in weight gain and feed conversion 
efficiency was observed. These reductions, however, could be reversed by 
adding methionine to the diet. 
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The effect of ammoniation on the effectiveness of vaccination against 
Newcastle Disease has been evaluated by feeding White Leghorn layer-bree-
ders with ammoniated corn (Boulton et al., 1981 ). No reduction in haemag-
glutination-inhibition (HI) titres was observed after vaccination in birds which 
had received either ammoniated/contaminated or ammoniated/uncontami-
nated corn. A significant reduction in HI titres was exhibited by those birds 
receiving untreated diets contaminated with 500 ppb aflatoxin. 
The effect on egg production and quality has also been studied in White 
Leghorn layer-breeders fed ammoniated diets (Hughes and Jones, 1979; 
Hughes et al., 1979). Ammoniation had no effect on egg production, egg 
weight, fertility or hatchability. However, reductions in feed consumption 
and weight gain were reported for those birds fed ammoniated diets. 
Pigs Ammoniated corn has been fed to weanling pigs (Keyl and Norred, 
1978). No reductions in weight gain or feed efficiency were observed after a 
period of 1 20 days. 
Dairy cattle The effect of ammoniated feeds on dairy cattle, and on the 
concentration of aflatoxin M 1 in milk, has been extensively studied (Park et 
al., 1988). Three feeding trials which used ammoniated groundnut cake and 
ammoniated cottonseed meal will serve to illustrate the typical results 
obtained. 
Ammoniated cottonseed meal and whole cottonseed were fed to lactating 
Holstein cows for 14 days. No aflatoxin M 1 could be detected in the milk, 
but 3-5 ng/litre could be detected after feeding untreated, contaminated feed; 
this is equivalent to q daily intake of approximately 6.0 (cottonseed) and 1.0 
(meal) Jlg aflatoxin B1 (McKinney et al., 1973). 
The effect of feeding ammoniated groundnut cake at 5-17 ppb aflatoxin 
B1 to Holstein Friesian cows over a 16-month period has also been investi-
gated (Fremy et al., 1987). No aflatoxin M 1 levels in excess of 0.01J.1g/litre 
were observed. The contaminated, untreated diet containing 20% contami-
nated groundnut cake, had approximately 220 ppb aflatoxin B1• 
The effect of ammoniation at low and medium pressure on the carry-over 
of residual aflatoxin B1 into milk was studied (Coker et al., 1995). Six groups 
of 10 Holstein cows were fed the diets shown in Table 4. There were no stat-
istically significant differences between diets B, C and D, and it was con-
cluded that the incorporation of ammonia-detoxified groundnut meal into 
dairy feed does not enhance the carry-over of aflatoxin from feed to the milk. 
Table 4 The percentage carry-over of aflatoxin B1 into milk as aflatoxin M 1 
Diet Aflatoxin 81 in Treatment Percentage 
feed (J..Lg/kg) carry-over 
A 42.5 Untreated groundnut meal (GNM) at 615 ~tg/kg 0.86 
B 4.1 Low pressure detoxified GNM at 43 J..Lg/kg 1.20 
c 3.4 Medium pressure detoxified GNM at 21 J..Lg/kg 1.72 
D 3.0 Uncontaminated GNM + GNM at 615 J..Lg/kg 1.59 
The presence of aflatoxin in feedstuff is causing severe economic losses 
and threatening human health throughout the world, and the imposition of 
legislation by importing countries within the developed world is highlighting 
the aflatoxin problem within the exporting countries of the Third World. 
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The chemical detoxification of contaminated feeds has a major role in the 
prevention of economic loss and human disease. Although the use of 
ammonia as a detoxification reagent has been very widely investigated and 
commercially exploited, the use of ammoniated commodities as animal feeds 
has not been widely accepted. This acceptance will not be forthcoming until 
general agreement has been reached on the toxicological implications of 
ammoniation. The US FDA's Center for Veterinary Medicine has established 
a Public Master File as a repository for information on the toxicology of 
ammoniated feeds to enable data on this matter to be effectively reviewed. 
THE METABOLISM OF MYCOTOXINS 
An examination of the metabolic fate of aflatoxin 81, ochratoxin A and fumo-
nisin 81 will illustrate the importance of the metabolic process in determining 
toxicity, and in determining exposure to mycotoxins, by measuring (a) myco-
toxin-macromolecular conjugates (b) the parent mycotoxin and (c) biochemi-
cal change initiated by the mycotoxin. 
The metabolism of aflatoxin 
Numerous animal studies (in vivo, and using animal tissues in vitro) have 
been carried out on the metabolic fate of the aflatoxins, primarily aflatoxin 
81 • There have also been limited studies on the measurement of aflatoxin 81 
and its metabolites in the blood, urine, milk and isolated tissues of humans. 
The metabolic fate of the aflatoxins may be considered under the headings 
of administration, absorption, transformation (activation and detoxification), 
distribution and excretion. 
Administration 
Under natural conditions, exposure to the aflatoxins may occur orally (by 
food ingestion) and by tracheal and bronchial absorption (by the inhalation 
of contaminated dust). In addition to these 'natural' routes, intraperitoneal 
(ip), intravenous (iv) and dermatitic administration have been used under 
experimental conditions. 
Absorption 
Studies using radio-labelled aflatoxin 8 1 in rats and monkeys have demon-
strated that there is little difference in the distribution and excretion of the 
toxin after either oral or ip administration; this suggests that absorption fol-
lowing oral exposure is complete (Wogan et al. , 1967; Dalezios et al. , 1973). 
Further studies with sheep and rats have shown that after absorption the afla-
toxins are transported via the blood and not via the lymphatic system 
(Wilson et al., 1985; Kumagai, 1989). 
Aflatoxin 81 can also be absorbed rapidly, by passive diffusion, from the 
small intestines (especially the duodenum) into the mesenteric venous blood. 
Given the lipophilic nature of aflatoxin 81, the composition of the intestinal 
epithelium is an important criterion. Hsieh and Wong (1994) found that over 
50% of radio-labelled toxin disappeared from the duodenum within 1 h, 
appearing in the venous blood as water-soluble metabolites, protein adducts 
and free toxin. Protein adducts (in which the aflatoxin is linked to the lysine 
component of serum albumin) represented over 50% of the total radio-
activity; the water-soluble metabolites occurred in only minor quantities. 
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Free aflatoxin B1 represented less than 33% of the labelled material, the 
concentration absorbed decreasing with time, presumably as a result of gas-
tro-intestinal metabolism. Although the liver is regarded as the main site of 
aflatoxin transformation, gastro-intestinal metabolism will reduce the 
exposure of the liver to aflatoxin B1 and, in terms of hepatic toxicity, is an 
important means of detoxification. Importantly, the administration of low 
doses (comparable to human exposure) of toxin to rat duodenum resulted in 
the absence of free aflatoxin B1 from the circulating blood. 
No evidence has been found for the reabsorption of aflatoxin metabolites 
resulting from entero-hepatic recirculation. 
Transformation 
The transformation of aflatoxin B1 results in both the activation and the 
detoxification of the toxin and may be considered as occurring in two 
phases: the first phase is the transformation of the toxin to a selection of 
metabolites; the second is the conversion of some of these metabolites to 
either water-soluble conjugates or macromolecular adducts. The transforma-
tion process is modulated by numerous factors including the genetic make-
up of the species, nutritional and health status, and exposure to metabolic 
modifiers in foodstuffs. 
The major metabolites of aflatoxin B1 include: aflatoxin Br8,9-epoxide, 
-8,9-dihydro-8,9-diol; the aflatoxins B2a, P1 , M 1 and Q1 ; and aflatoxicol, afla-
toxicol H 1 and aflatoxicol M 1 (see Figure 17) (Essigmann et al., 1982). 
However, not all metabolites have been identified in all species. Their role in 
the toxicity of aflatoxin B1 will now be discussed under the sub-headings 
activation and detoxification. 
Activation 
In the liver, aflatoxin B1 may interact with both DNA and protein to elicit the 
carcinogenic and acutely toxic effects of aflatoxin, respectively. Initially, afla-
toxin B1 is converted by P450 cytochromes to the highly reactive aflatoxin 
B1-8,9-epoxide which, in turn, may be converted to aflatoxin B1-dihydrodiol 
(see Figure 17) (Baertschi et al., 1989). 
The carcinogenicity of aflatoxin B1 arises from its interaction with the gua-
nine moiety of DNA to produce the aflatoxin-N7-guanine adduct (Baertschi 
et al., 1989), whereas the acute toxicity of aflatoxin B1 is believed to stem 
from interaction between the dihydrodiol and protein amino groups to pro-
duce Schiff base adducts (Appleton et al., 1982). 
The aflatoxin metabolites M 1 and P1 can also form DNA adducts 
(Essigmann et al., 1983). lt has been hypothesized that aflatoxin B2 can be 
reduced to B1 which, in turn, undergoes epoxidation and binding to DNA 
(Groopman et al., 1981 ). Similarly, there is evidence that aflatoxin G1 can 
bind to DNA (Garner et al., 1979). 
Studies using guinea pig kidney microsomes have indicated that the two 
enzyme systems, cytochrome P450 and prostaglandin H synthase (PHS), are 
equally active in the formation of DNA adducts (Liu et al., 1990). However, 
prostaglandin H synthase was only responsible for 1-2% of DNA-binding in 
guinea pig liver microsomes, reflecting the higher P450/PHS ratio in the 
guinea pig liver. 
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Aflatoxin B1 is also converted to a DNA-binding species by the human 
bronchus and colon in culture. The bronchus is more active than the colon 
(Autrup et al., 1979). 
Aflatoxicol is a major aflatoxin B1 metabolite in rat plasma (Wong and 
Hsieh, 1978). Post-mitochondrial fractions of I iver from a variety of species 
have been shown to have relatively high activity for aflatoxicol formation in 
vitro (Loveland et al., 1979). A cytosolic reductase (believed to be 17-keto-ste-
roid dehydrogenase) which catalyses the conversion of aflatoxin B1 to aflatoxi-
col has been isolated from chicken liver (Chen et al., 1981; Neal, personal 
communication). Aflatoxicol is reported to have carcinogenic potency equiv-
alent to that of aflatoxin B1 and about 70% the mutagenicity (Schoenhard et 
al., 1981; Coulombe et al., 1982). Since it can be readily converted back to 
aflatoxin B1, it has been proposed that aflatoxicol may act as a 'reservoir' for 
aflatoxin B1 in vivo, thereby prolonging the lifetime of the toxin in the body. 
Detoxification 
The detoxification process occurs via the conversion of aflatoxin B1 to less 
active hydroxylated metabolites, such as the aflatoxins M 1, Q1 and P1, and 
via the formation ofthe glutathione conjugate and glucuronides (see Figure 17). 
However, whereas aflatoxin Q1 is much less acutely toxic, mutagenic and 
carcinogenic than aflatoxin B1, aflatoxin M 1 is a relatively potent carcinogen 
and only slightly less acutely toxic than aflatoxin 8 1 (Hsieh et al., 1974; 
Hendricks et al., 1980; Coulombe et al., 1982). The glutathione (GSH) conju-
gate of aflatoxin B1-epoxide has been identified as the major metabolite in 
the bile of rats (Holeski et al., 1987). GSH conjugation is mediated by cyto-
solic glutathione S-transferases (GSTs) and is an important reaction when 
determining the suceptibility of species to the toxic effects of aflatoxin 
(Ramsdell and Eaton, 1990a). 
The important role played by GSTs in the detoxification process can be 
clearly illustrated by comparing the susceptibility of the mouse and rat to 
tumour induction. Although the mouse has a very high microsomal epoxida-
tion activity, it is very resistant to the carcinogenicity of aflatoxin B1, presum-
ably because of its very high level of simultaneous GST activity (Hayes et al., 
1991 ). Of particular significance is the occurrence, in the mouse, of an alpha 
class GST (YC2) which is highly active towards aflatoxin B1-epoxide, and 
which is not found to any significant extent in adult rats or humans (Neal, 
personal communication). 
One particular GST (the mu form M1 a-1 a) has shown considerable activity 
towards the aflatoxin 8 1 endo-epoxide (Raney et al., 1992). However, 
although human microsomes produce both endo- and exo-epoxides, it 
appears that the exo-epoxide binds primarily to DNA. The identification of 
the most important GSTs, and their distribution within and between popula-
tions, is crucial to understanding the manifestation of aflatoxin toxicity. 
(About 50% of Caucasians, for example, possess a gene deletion for the GST 
mu form M1 a-1 a.) 
The glucuronides of aflatoxicol and aflatoxins M 1, P1 and Q 1 have been 
identified as biliary metabolites of aflatoxin B1 (Metcalfe and Neal, 1983; 
Loveland et al., 1984; Eaton et al., 1988). Current data suggest that conju-
gation occurs more readily at the aromatic hydroxyl group in aflatoxin P1 
than at the aliphatic hydroxyls in the aflatoxins M1 and Q1, although the 
importance of M 1 and Q 1 glucuronidation has still to be resolved (Eaton et 
al., 1994). 
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An index of species susceptibility to aflatoxin B1 has been produced using 
the activation/inactivation (detoxification) ratio in which activation = (rate of 
B,-epoxide formation)~( rates of B1-epoxide and aflatoxins M1, P1 and Q 1 
formation), and inactivation = (rate of cytosolic B1-epoxide conjugation with 
GSH)/(rate of microsomal B1-epoxide formation) (Degen and Neuman, 1981). 
The susceptibility indices for the rat, mouse, monkey and man are shown in 
Table 5; they are based on data produced in vitro using hepatic microsomes 
and cytosol. The high activation/inactivation index (18.00) for humans results 
mainly from the very low inactivation ratio (0.008) compared to the other 
species. Conversely, the low activation/inactivation index (0.13) for the 
mouse can be attributed to a high inactivation ratio (2.9). 
Table 5 The activation/inactivation index for a variety of species 
Species 
Rat 
Mouse 
Monkey 
Human 
Activation 
0.42 
0.39 
0.09 
0.14 
Inactivation 
0.068 
2.9 
0.033 
0.008 
Activation/inactivation 
6.20 
0.13 
2.80 
18.00 
Any evaluation of species susceptibility must also consider the kinetics of 
the metabolic pathways involved in the activation and detoxification of afla-
toxin. For example, when comparing rat, mouse, monkey and man, the pat-
terns of liver microsomal oxidation of aflatoxin B1 vary significantly with 
changes in substrate concentration. In rat and human microsomes, the pro-
portion of aflatoxin B1 converted to the epoxide increases with decreasing B1 
concentration, indicating that humans may be relatively susceptible to afla-
toxin carcinogenesis at the low exposure levels typically experienced 
(Ramsdell and Eaton, 1990b). 
Non-nutritive components of foods of plant origin, including cruciferous 
vegetables such as broccoli, Brussels sprouts and cabbage, can modulate the 
biotransformation, DNA-binding and carcinogenesis of aflatoxin B1. Ramsdell 
and Eaton (1988) reported that broccoli appears to enhance the detoxification 
of the aflatoxin epoxide in rats. Plants of the Allium genus have also shown 
anti-carcinogenic effects. Organosulphur compounds in garlic, and capsaicin 
in chilli peppers, are reported to decrease aflatoxin-DNA binding in vitro 
(Tadi et al., 1991; Teel, 1991 ). 
Distribution 
After absorption from the intestine, aflatoxin B1 rapidly enters the liver 
through the hepatic portal vein. The toxin is heavily concentrated in the liver 
after oral, ip and iv administration. Much less aflatoxin accumulates in the 
kidney. When radio-labelled aflatoxin B1 was administered ip to rats, approxi-
mately 17% of the label was present in the liver within 30 min.; the kidneys 
and the eviscerated carcass contained about 5% and 27%, respectively. 
Traces (<0.5%) of labelled material were present in the adrenal glands, brain, 
heart, pancreas, spleen, thymus and testes (Wogan et al., 1967). The radio-
activity diminished rapidly, only 10% remaining in the liver after 2 h. In a 
similar experiment, Holeski et al. (1987) found that 2 h after administration, 
70% of the residual toxin was in the form of covalently bound adducts. An 
orally-administered monkey still retained about 1% of the dose five weeks 
after administration (Dalezios et al., 1973). 
45 
Excretion 
Excretion of aflatoxin 81 occurs primarily through the biliary pathway and to 
a lesser extent, the urinary pathway, and by excretion into the milk of lactat-
ing animals. 
Biliary excretion When radio-labelled aflatoxin 81 was fed to rats, the plasma 
half-life for radioactivity was 91.8 h; 23 days after dosing, 70% of the radio-
activity had been excreted, 55% in the faeces and 15% in the urine (Coulombe 
and Sharma, 1985). In a further study, the rate of biliary excretion peaked at 30 
min.; the major metabolites were the aflatoxin-glutathione adduct (about 53% of 
the total biliary radioactivity) and aflatoxin P1 glucuronide (about 1 0%). 
Urinary excretion Approximately 15% of radio-labelled aflatoxin 8 1 was 
excreted in urine 20-24 h after ip administration to rats. The major metab-
olites were the aflatoxins M 1 (45% radioactivity) and P1 (<1 0%), and afla-
toxin B1-N7-guanine (16%). The latter is the major degradation product of 
hepatic 81-DNA adducts (Groopman et al., 1994). Eighty per cent of excreted 
B,-guanine was measured in the urine during the 48 h period following dos-
ing, and a dose-dependent correlation between 81 and 81-guanine was 
observed in male rats (Bennett et al., 1981; Essigmann et al., 1982). 
Aflatoxin M 1 was also the major urinary metabolite following oral admin-
istration of labelled aflatoxin 81 to monkeys (Dalezios et al., 1973). 
Aflatoxin P1 is the major metabolite in the mouse. The mouse is the only 
species known to excrete aflatoxin Q1 in urine (Wei et al., 1985). 
Analysis of urine collected from humans in the Guangxi region of China showed 
that the same metabolites were present as in rats (the aflatoxins M 1, P1 and aflatoxin 
81-guanine); aflatoxin M1 was the major metabolite (Groopman et al., 1985). 
Males excreted about 1-2% of ingested 81 whereas females excreted lower levels. 
Excretion through cow's milk Aflatoxin 81 in dairy feed can be metabo-
lized and transferred to cow's milk in the form of aflatoxin M 1 . The percentage 
carry-over rate typically lies within the range of 1 to 5%, depending, for 
example, on the level of aflatoxin in the feed and the productivity of the cow. 
Generally, the carry-over rate increases as the feed contamination level 
decreases and as the cow productivity increases. However, the carry-over rate 
varies significantly from cow to cow and, on an individual cow basis, from day 
to day. Coker et al. (1995) reported a mean carry-over rate of 1.5% when cows 
were fed diets (including ammonia-treated diets) containing approximately 
3.0 11glkg aflatoxin 8 1 (see Table 4). In the same study, a diet containing 
approximately 40 11glkg aflatoxin 81 resulted in a carry-over rate of 0.9%. 
When goats were dosed with very low levels of radio-labelled aflatoxin 
81, aflatoxin Q 1 and aflatoxicol were identified in the milk, in addition to 
aflatoxin M 1 (Helferich et al., 1986). 
A hydroxy derivative of aflatoxin M 1 known as aflatoxin M4 (see Figure 18) 
has been reported to eo-occur with aflatoxin M 1 (at levels up to 16% of afla-
toxin M 1); the toxicity and carcinogenicity of aflatoxin M 4 is reported to be 
greater than that of the aflatoxins 81 and M 1 (Lafont and Lafont, 1987). 
Excretion through human milk The presence of aflatoxins in human 
breast milk has also been reported. In Africa (the Sudan, Ghana, Kenya and 
Nigeria), the aflatoxins M 1, M 2, 8 1, 82, G1 and G2 have all been found in 
breast milk (Lamplugh et al., 1988; Maxwell et al., 1989). Aflatoxin M 1 was 
the major metabolite, occurring at concentrations ranging from 20 to 
1800 ngllitre in Ghana. 
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The metabolism of ochratoxin A 
According to an IARC evaluation, OA causes renal toxicity, nephropathy and 
immunosuppression in several animal species (IARC, 1993e). However, 
although there is sufficient evidence in experimental animals for the carcino-
genicity of OA, evidence for its carcinogenicity in humans is inadequate. 
The possible role of OA in the aetiology of human disease, including the 
possible linkage between exposure to OA and both Balkan endemic nephro-
pathy and urinary tract tumours, has led to studies of the metabolic fate and 
toxicity of the parent toxin and its metabolites. 
No data are available on the absorption, distribution, metabolism and 
excretion of OA in humans. However, it has been reported that in vitro, OA 
binds with extremely high affinity to unidentified macromolecules in human 
plasma (saturation occurring at the low level of 10-20 ng/ml OA in serum) 
and to plasma proteins ((Stojkovic et al., 1984; Hult and Fuchs, 1986; 
Hagelberg et al., 1989). 
The DNA adducts induced in various mouse organs after treatment with 
the toxin show that OA is a genotoxic carcinogen. Pfohi-Leszkowicz et al. 
(1993) compared DNA adducts observed in OA-treated mice with DNA 
adducts from patients with urinary tract tumours (and with a suspected past 
exposure to OA). The analysis of 32P post-labelled autoradiograms suggested 
that some of the DNA adducts from OA-treated mouse kidney eo-migrated 
with those detected in humans. Although it is not yet known if the adducts 
retain the OA moiety or one of its metabolites, the identification of DNA 
adduct patterns provides a potential tool for the molecular dosimetry of OA 
exposure in humans. 
OA administered to rats by gavage at about 4 ppm was found in the fat, 
small intestine, testis, kidney, liver, heart, lung, spleen, stomach, muscle and 
brain (in decreasing order of concentration) after 24 h. After 48 h, the level 
in fat had increased, whereas all other levels had decreased (Kane et al., 
1986). 
In ruminants, low levels of OA are rapidly hydrolysed by the rumina! flora 
(Galtier and Alvinerie, 1976; Hult et al., 1976). However, OA was detected 
in the kidney, milk and urine of cows when a high dose of OA was ingested 
(Ribelin et al., 1978; Shreeve et al., 1979). 
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The plasma elimination half-time of OA varies very significantly between 
animal species. Hagelberg et al. (1989) report that it varies from 0.68 h in 
fish, to 120 h in rats and 510 h in monkeys. 
OA can be metabolized in vitro to ochratoxin et, (4R) and (45)-4-hydr-
oxyochratoxin A, and 1 0-hydroxyochratoxin A (see Figure 19). The incubation 
of OA with rat, rabbit, pig and human liver microsomes produced both the 
4R and 45-hydroxy derivatives, the ratio between the two epimers depending 
on the animal species (St0rmer et al., 1981, 1983). The transformations were 
P450-dependent (Oster et al., 1991 ). Rabbit liver microsomal treatment also 
produced 1 0-hydroxyochratoxin A. Incubation of OA with primary rat hepa-
tocytes produced the 4R-hydroxy epimer as the major metabolite (Hansen et ' 
al., 1982). 
Fink-Gremmels et al. (1995) reported the formation of five different pheno-
barbital-inducible metabolites when pig microsomes were exposed to OA. 
Six stable metabolites were detected in the supernatant of primary cultures of 
pig hepatocytes, representing 50% of the initial OA concentration. The major 
metabolite has been characterized as the 4-hydroxy-derivative of OA 
(although the precise epimer has not been reported). 
OA is hydrolysed to ochratoxin et by, for example, homogenates of duo-
denal, ileal, pancreatic and caecal tissues (Suzuki et al., 1977; Galtier, 1978). 
""oc#? > ~CH, 
Ochratoxin A 
©1-cH.-!::NH-~wO  0 0 rcY ,OOH , RwOH 0 
'H ~CH2-CH-NH-C 0 0 
'CH~ H 
10-Hydroxyochratoxin A Cl ' , ' ,eH, 
cl H OH 
(4R)-4-Hydroxyochratoxin A 
~ COOH o OH 0 ~'"_~,_,,_uW:. 
Cl HO H (451-4-Hydroxyochratoxin A 
From Storen et al. (1982); Stormer et al. (1983) 
Figure 19 Metabol ites of ochratoxin A 
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The formation of (4R) and (45)-4-hydroxyochratoxin A has been linked 
with cytochrome P450 forms which exhibit several similarities with rat 
CYP450 281 (Fink-Gremmels et al., 1995). The same workers have also dem-
onstrated that CYP450 isoenzymes belonging to the subfamilies 1 A 1, 1 A2, 
2C9 and 3A4 (expressed in genetically engineered 3T3 fibroblasts) are able 
to convert OA into mutagenic derivatives. However, further work is necessary 
on the fate of the Phase 1 metabolites of OA described above, and the role 
of glutathione conjugation in the transformation of OA has yet to be deter-
mined. 
The metabolites of OA are less acutely toxic than the parent compound 
(Chakor et al., 1988). However, Creppy et al. (1983) reported that the immu-
nosuppressive activity of (4R)-4-hydroxyochratoxin A is similar to that of the 
parent toxin. Furthermore, the metabolites obtained by the treatment of OA 
with isolated hepatocytes are mutagenic when subjected to the Salmonella/ 
microsome assay (Hennig et al., 1991 ). The non-mutagenic activity of the 
microsomal metabolites of OA is believed to be the result of the lower meta-
bolic capacity of microsomal incubations, rather than a qualitative difference 
in metabolic products. 
When OA was administered to mice by gavage, 4-hydroxyochratoxin A 
was detected in the intestine, liver and bile. Up to 68% of biliary OA was in 
a conjugated form after 24 h (Chakor et al., 1988). 
The biliary excretion of OA is very efficient. For example, when radio-
labelled (3 H) OA was administered to rats and mice either orally or intramus-
cularly, entero-hepatic circulation resulted in the detection of radio-label in 
the intestinal contents and serum (Fuchs et al., 1988; 8reitholtz-Emanuelsson 
et al., 1992). 
The relative contribution of each excretory route for OA varies with the 
species under study (Kuiper-Goodman and Scott, 1989). In albino rats for 
example, approximately 25% of the toxin was excreted in the urine as ochra-
toxin rt, whereas 6% and 1-1 .5% was excreted as OA and (4R)-4-hydroxyo-
chratoxin A, respectively. 
The concentration of specific OA metabolites in the urine was also strain-
dependent. The ratio of OA to 4-hydroxyochratoxin A in the urine of dark 
Agouti female rats, for example, was two to five times higher than in Lewis 
rats (Castegnaro et al., 1989). 
The metabolism of fumonisin 81 
The fumonisins 81 (F81) and 82 (F82), which are the most commonly occur-
ring in nature, are reviewed with the emphasis on fumonisin 81. 
Oral administration of F81 to male rats produced hepato-cellular carcino-
mas, inducing the formation of foci (y-glutamyltranspeptidase-positive) hepa-
tocytes (IARC, 1993d). No data are available on the carcinogenicity of F82. 
F81 causes outbreaks of leukoencephalomalacia (LEM) in horses and pul-
monary oedema in pigs. lt is toxic to the central nervous system, liver, pan-
creas, kidney and lung in a number of animal species. F82 is hepatotoxic in 
rats (IARC, 1993). However, neither F81 or F82 were mutgenic to 5. typhi-
murium, nor did they induce unscheduled DNA synthesis in rat hepatocytes, 
either in vitro or in vivo. 
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When FB1 was administered to rats by multiple ip injection, the effects 
included dehydration, nephrotoxicity and immunotoxicity (Bandy et al., 
1995). Suzuki et al. (1995) reported that urine volume, proteinuria, enzymuria 
and ion transport were sensitive indicators of early FB1-induced nephrotoxicity. 
FB1 also altered sphingolipid metabolism and disrupted the barrier func-
tion of endothelial cells in culture (Ramasamy et al., 1995). Injury to vascular 
endothelial cells, and the concomitant leakage of fluid into underlying tis-
sues, could be a predisposing factor in both LEM in horses and pulmonary 
oedema in pigs. 
Although the molecular mode of action of the fumonisins is not known, 
they appear to bear a remarkable structural similarity to sphingosine, the 
long-chain backbone of sphingomyelin and other sphingolipids. 
(Sphingolipids are believed to be involved in the regulation of cell growth, 
differentiation and neoplastic transformation.) Consequently, the ability of 
FB1 to inhibit the formation of the sphingolipids has been studied in vitro 
and confirmed using both rat hepatocytes and a pig kidney cell line LLC-PK1 
(Wang et al., 1991; Yoo et al., 1992). Merrill et al. (1993) also studied the 
role of FB1 in the inhibition of the biosynthesis of the sphingolipids in rat 
(Swiss 3T3) fibroblasts. The addition of FB1 led to a large accumulation of 
sphinganine and sphingosine by inhibiting the metabolism of sphinganine by 
the enzyme N-acyltransferase. In turn, the accumulation of the sphingoid 
bases stimulated a doubling of DNA synthesis. The same group of workers 
also argue that FB1 can be regarded as a tumour promoter because of the 
mitogenic properties of the accumulated sphingoid bases at cellular concen-
trations of 0.2-2.0 nmol/mg protein (Schroeder et al., 1994). 
Shephard et al. (1992) monitored the metabolic fate of 14C-Iabelled FB1 in 
rats following either ip or oral administration. For the ip-administered toxin, 
66, 32 and 1% of the radioactivity were recovered in the faeces, urine and 
liver, respectively, after 24 h of dosing. When administered orally, all the 
label occurred in the faeces. Similar results were obtained when FB1 was 
administered to vervet monkeys. 
lt appears that FB1 (and possibly other fumonisins) is rapidly excreted after 
ingestion in a largely unchanged form. Consequently, the pathological effects 
induced by FB1 in the rat must be caused either by extremely low concen-
trations of toxin retained by the rat, or by secondary reactions initiated by 
the presence of F B 1 . 
THE BIOMONITORING OF MYCOTOXINS 
Biomonitoring of aflatoxins 
The introduction of methods for biomonitoring individual members of a 
population is a major development which will contribute significantly to the 
confirmation of the perceived linkage between mycotoxin exposure and 
human disease. 
The development of biological markers (biomarkers) for the aflatoxins is 
based on knowledge of the metabolism and the critical macromolecular 
adduct formation of these toxins. Aflatoxin biomarkers may be used as a 
means of estimating the exposure of individuals to these toxins, and of pre-
dicting the risk of developing liver cancer and other diseases. 
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The role of aflatoxin biomarkers in humans is now discussed in terms of 
their role as markers of internal dose, biologically effective dose, early bio-
logical effect, and susceptibility. 
Markers of internal dose 
Markers in urine 
Aflatoxin M 1 is a predominant metabolite in human urine. Its presence may 
be detected by thin layer chromatography (TLC), high performance liquid 
chromatography (HPLC) and enzyme-linked immunosorbent assay (ELISA). 
lmmunoaffinity columns have also been used to clean up the samples prior 
to quantification. 
Zhu et al. (1987) analysed 252 urine samples over a three-day period in 
the Guangxi Region of China, to compare dietary exposure to the aflatoxins 
with urinary excretion of aflatoxin M 1 • Between 1.2 and 2.2% of the dietary 
aflatoxin B1 appeared in the urine as aflatoxin M 1, with a good correlation 
(r = 0.65) between the ingested and excreted toxins. 
Markers in milk 
The occurrence of aflatoxin M 1 in human breast milk is an indicator of both 
exposure of individual mothers to aflatoxin in food, and of the exposure of 
their infants to this toxin. However, a good correlation between levels of 
ingested aflatoxin B1 and levels of aflatoxin M 1 in human breast milk has not 
been reported. 
In a study in The Gambia, milk from five lactating mothers was collected 
once a day for four to five days and analysed for aflatoxins by a combination 
of immunoaffinity clean-up and HPLC quantification (Zarba et al., 1992). The 
carry-over of aflatoxin, in the form of aflatoxin M 1 , varied from 0.09 to 
0.43%. Aflatoxin G1 was also found in the milk of three of the five women. 
The occurrence of aflatoxin M 1 in human breast milk was also studied in 
Zimbabwe and France (Wild et al., 1987). In Zimbabwe, 11% of 54 samples 
of milk contained up to 50 pglml (approximately 0.05 ppb) aflatoxin M 1; 
none of the 42 samples collected in France was contaminated. 
Markers in blood 
Unmetabolized aflatoxin B1 in human blood serum has been used as an indi-
cator of recent exposure to aflatoxins in food. For example, aflatoxin B1 has 
been detected in serum samples collected in japan, Nigeria and Sudan 
(Hendrickse et al., 1982; Tsuboi et al., 1984; Denning et al., 1988). The 
detection methods used were ELISA and HPLC; up to 3 nglml (approximately 
3 ppb) B1 were detected. In a recently reported study (Denning, personal 
communication) in The Philippines, blood samples were collected from 115 
children with acute lower respiratory infection (ALRI). Aflatoxin B1 was 
detected in 33% of the serum samples, with a mean value of 462 pglml 
(approximately 0.5 ppb). There was a strong association between those serum 
samples with no detectable aflatoxin and patient death, perhaps reflecting, in 
turn, an association between anorexia (and the presumed concomitant 
inability to metabolize aflatoxin) and poor patient outcome. 
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In a study carried out during the dry season in Songkla, Thailand, 
Denning et al. (1990) demonstrated that aflatoxins can cross the placental 
barrier in humans. In a group of 35 mothers, 17 of the cord sera samples 
contained the aflatoxins 81, G1 and Q 1 whereas only two maternal sera 
samples were contaminated. 
Similarly, the aflatoxins M 1, M 2 , 81, 82 , G1 and G2 have been detected in 
cord sera from Ghana (34% of 188 samples), and aflatoxins M 1, M 2 and 82 
were present in cord sera collected in Nigeria (12% of 78 samples) 
(Lamplugh et al., 1988). 
Markers of biologically effective dose 
Two biomarkers of biologically effective dose have been developed. The first 
is a urinary aflatoxin 81-DNA adduct and the second is an adduct between 
aflatoxin 81 and serum protein. 
Aflatoxin BrDNA adduct in urine 
The urinary excretion kinetics of specific metabolites after a single exposure 
to aflatoxin 8 1 were studied in rats. Aflatoxin-N7-guanine (the primary 8 1-
DNA adduct; see Figure 17) accounted for 7.5% of the total detectable afla-
toxins, and the aflatoxins P1, Q 1, M 1 and 81 accounted for 31.5, 3.0, 2.2 and 
0.3% of total aflatoxins, respectively (Groopman et al., 1992). During the 
24 h after exposure, an excellent correlation (r = 0.99) existed between the 
oral dose of aflatoxin 81 and the urinary aflatoxin-N7-guanine adduct. The 
other metabolites showed no such relationship. 
Systematic evaluation in several human populations has validated the afla-
toxin-guanine adduct as a measure of biologically effective dose. Studies per-
formed in Kenya and China, for example, have confirmed the correlation 
between human exposure to aflatoxin 81 and urinary aflatoxin-guanine 
adduct (Autrup et al., 1987; Groopman et al., 1992). 
In the Mu rang' a district of Kenya, 12.6% of over 1000 urine samples con-
tained the aflatoxin-guanine adduct. The levels of the adduct reflected 
regional differences, with the highest concentrations being found in samples 
from the Western Highlands and Central Province. 
The Guanxgi Region is one of the areas of high liver cancer incidence in 
China. Dietary exposure to aflatoxin (mainly from corn) and corresponding 
levels of urinary aflatoxin metabolites were measured, over one week, in a 
group of 30 males and 12 females. A combination of immunoaffinity clean-
up and HPLC was used to determine the levels of a range of metabolites. 
The most commonly detected compounds were aflatoxin-guanine adduct and 
the aflatoxins M 1, P1 and 8 1• However, acceptable correlation between 
exposure to aflatoxin and urinary metabolic excretion occurred only for the 
aflatoxin-guanine adduct (r = 0.65) and aflatoxin M 1 (r = 0.55). 
Aflatoxin-albumin adduct in blood serum 
Blood samples from the same subjects in the Guanxgi Region of China were 
also analysed for the aflatoxin-serum albumin adduct (see Figure 17) using a 
combination of immunoaffinity clean-up and competitive radio-immunoassay 
(RIA) (Gan et al., 1988). A highly significant correlation of adduct level with 
aflatoxin exposure (r = 0.69, P < 0.000001) was observed. It was calculated 
that between 1.4 and 2.3% of ingested aflatoxin 81 appeared as the serum 
albumin adduct. 
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The use of the aflatoxin-albumin adduct as a marker of the biologically 
effective dose offers two advantages over the measurement of the aflatoxin-
DNA adduct. First, whereas the aflatoxin-DNA adduct reflects exposure to 
aflatoxin on the previous day, the level of aflatoxin-albumin adduct is a 
measure of chronic exposure to aflatoxin over the previous two to three 
months (Hall and Wild, 1994). Second, the collection of finger-prick samples 
of peripheral blood is far more convenient than the collection of urine. 
The aflatoxin-albumin adduct has been measured in children and adults 
from a variety of African and other countries. In Africa, between 12 and 
100% of the samples contained the adduct whereas in Thailand, levels and 
incidence were lower. Studies in France and Poland failed to identify any 
positive sera samples (Hall and Wild, 1994). 
In The Gambia, a study of 30 pregnant women demonstrated a good cor-
relation (r = 0.52, P = 0.001) between levels of the aflatoxin-albumin adduct 
rn sera from maternal venous blood and the umbilical cord (Wild et al., 
1991 ). 
Markers of early biological effect 
Measures of mutation spectra 
Studies in the field of molecular biology have led to a better understanding 
of the genetic alterations which occur during the progression from initiation 
to tumour formation, and to the development of sensitive tests for the diag-
nosis of tumours. 
The p53 tumour suppressor gene is mutated in more than 50% of all 
human tumours (Hollstein et al., 1991 ). The numbers and types of mutations 
in this gene (the mutation spectrum) are not equally distributed, but occur in 
specific hot-spots which vary with the aetiology of tumour formation. For 
example, studies on liver cancer tumours in areas with a high exposure to 
the aflatoxins (Qidong, China; Mozambique) showed a high frequency of 
G ~ T transversion at codon 249 of the p53 gene (Bressac et al., 1991; Hsu 
et al., 1991 ). To date, the same mutation has rarely been observed in North 
America, Europe or Japan where exposure to the aflatoxins is low and does 
not appear to be related to hepatitis B virus infection (Ozturk et al., 1991 ). 
In vitro studies using the human p53 gene have shown that codon 249 is 
the preferential site for the formation of aflatoxin-N7 -guanine adducts 
(Pusieux et al., 1991 ). Exposure of cultured human liver cells to aflatoxin 81 
has produced codon 249 mutations in vitro (Neal, personal communication). 
Although the link between aflatoxin exposure and specific p53 gene 
mutations in human populations has still to be confirmed, the gene mutation 
spectrum has considerable potential as a marker for exposure to, and damage 
from, the aflatoxins. Currently, mutations detected in the p53 gene of epi-
thelial cells shed into the urine are used to diagnose bladder cancer 
(Sidransky et al., 1991 ). Another possibility is the examination of DNA from 
lymphocytes isolated from blood samples for evidence of mutation (Neal, 
personal communication). 
Measures of immunosuppressive activity 
Although the effect of aflatoxin on susceptibility to infection has been clearly 
demonstrated in a range of animal species (including chickens, turkeys, pigs, 
guinea pigs, calves, rabbits, rats, mice and cows), little or no data are avail-
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able on the immunosuppressive effects of aflatoxins in human populations 
(Pier and Mcloughlin, 1985; Denning, 1987). Current tests for immunosup-
pressive activity include (a) neutrophil monocyte activity and (b) lymphocyte 
transformation (Denning, personal communication). 
Markers of susceptibility 
Measures of genetic variation in metabolism 
Susceptibility to a particular agent will depend on the ability of individuals to 
absorb, distribute and metabolize that agent, and on the nature of the meta-
bolic process. The ability of individuals to repair damage inflicted by the 
agent will also contribute to the level of susceptibility. 
Studies with human liver microsomes have shown that the cytochrome 
P450s involved in the activation (epoxidation) of aflatoxin B1 varies with the 
level of exposure. The activation of high levels of aflatoxin B1, for example, 
is performed by cytochrome P450 3A4 (CYP3A4), with the simultaneous pro-
duction of aflatoxin Q1 (Shimada and Guengerich, 1989). Conversely, low 
levels of aflatoxin B1 (typical of human exposure) are activated by cyto-
chrome CYP 1 A2, with the simultaneous formation of aflatoxin M 1 • 
Since cortisol is also a substrate for CYP3A4 and is metabolized to 6B-
hydroxycortisol, the ratio of these two steroids in the urine can be used as a 
marker for hepatic CYP3A4 activity Uoellenbeck et al., 1992). The steroids 
may be determined either by ELISA or HPLC methods. A marker for CYP 1 A2 
activity has not been reported. 
To date, biomarkers of cytochrome activity have not been applied to 
populations exposed to substantial levels of aflatoxins. 
Although some workers have accorded the enzyme, glutathione S-transfer-
ase mu, a significant role in the detoxification (by conjugation to glutathione) 
of the aflatoxin epoxide metabolite, others have now demonstrated the 
importance of alpha class enzymes in the detoxification of aflatoxin in the 
mouse ((Liu et al., 1991; Raney et al., 1992; Neal, personal communication). 
Although an in vitro assay (involving trans-stilbene as the substrate) and a 
polymerase chain reaction (PCR)-based genotyping assay are available for the 
monitoring of glutathione S-transferase mu, these procedures have not been used 
in populations exposed to significant levels of aflatoxins (Zhong et al., 1991 ). 
Biomonitoring of ochratoxin A 
A variety of HPLC methods have been reported for the determination of OA 
in animal and human products. 
Phillips et al. (1983) developed a method for estimating OA in chicken 
kidney and human plasma, and Bauer and Gareis (1987) reported a method 
for OA in blood. 
One HPLC procedure for the determination of OA in kidney (and corn 
and barley) was subjected to an IUPAC collaborative study (Nesheim et al., 
1992). Briefly, extraction with chloroform:phosphoric acid was followed by 
liquid partitioning and solid phase extraction (SPE) (C18) clean-up. Reversed 
phase HPLC was then performed, using water:acetonitrile:acetic acid as the 
mobile phase, and fluorescence detection. 
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A combined SPE/C18 HPLC method for the determination of OA in pig 
serum has also been described by Takeda et al. (1991 ). The presence of OA 
was confirmed by temperature-controlled, pre-column methylation to par-
tially derivatize the sample toxin and afford a specified methyi-OA:OA ratio. 
A detection limit of 0.1 ng/ml OA in pig serum was reported. 
lmmunoaffinity clean-up cartridges have also been used in conjunction 
with HPLC for the determination of OA in kidneys and pig liver ((Bisson et 
al., 1994; Marley et al., 1995). In the pig liver test, a 1:1 ratio of methanol:-
phosphate buffered saline was used for extraction, followed by an immunoaf-
finity clean-up. The OA in the cleaned-up sample was quantified by reversed 
phase C18 HPLC in conjunction with fluorescence detection. 
OA and its metabolites were determined using an ion-pair reversed phase 
HPLC analysis method (Fink-Gremmels et al., 1993). This involved elution of 
a Spherisorb ODS 2 column (250 x 4.6 mm ID) with two buffered (pH 6.6) 
acetonitrile-based solvent systems containing tetrabutylammonium as the ion-
pairing agent. Fluorescence detection (335 nm excitation; 450 nm emission) 
was employed. 
Ion-pair reversed phase HPLC with fluorescence detection has also been 
used to detect OA in samples of blood and milk collected in Sweden 
(Breitholtz-Emanuelsson et al., 1993). A Pasteur pipette packed with silica gel 
was used for sample clean-up. The reported limits of detection and quantifi-
cation for OA were 10 and 40 ng/litre, respectively, for cow's and human 
milk; the limit of quantification in human blood was 60 ng/litre. OA was 
found in five (14%) of 36 samples of cow's milk and 23 (58%) of 40 samples 
of human milk. Blood samples were collected from 39 of the 40 human milk 
donors and analysed for OA. All samples were contaminated at a mean con-
centration of 167 ng/1 itre (range 90-940 ng/1 itre). The concentration of OA in 
human milk was :(0.1 of that in human blood . (However, the narrow con-
centration range in this study means that this value should be treated with 
some caution.) 
The application of an ELISA method to the analysis of OA in pig kidneys 
was reported by Clarke et al. (1994). The lowest reproducible OA detection 
limit in spiked pig kidney samples was 7.81 j.!g/kg, with an interassay co-effi-
cient of variation of 8.9%. Rabbit antisera had a high degree of cross-reaction 
with OA (and ochratoxin C), but not with ochratoxin B and rt- or 4-hydroxy-
OA. 
Biomonitoring of fumonisin 81 
Wang et al. (1992) concluded that the ratio of sphingosine to sphinganine 
could possibly be used as an early marker for exposure to the fumonisins. A 
method involving the reversed phase HPLC determination of sphingosine and 
sphinganine in urine is currently under development (Wild, personal com-
munication). - ' 
Shephard et al. (1992) have developed a reversed phase HPLC method for 
the determination of FB1 in plasma and urine. A detection limit of 50 ng/ml 
was reported when a solid-phase, anion-exchange clean-up column, pre-
column derivatization with ortho-phthaldialdehyde, and fluorescence detec-
tion, were employed. 
The presence of FB1 (and FB2) in milk has been determined using immu-
noaffinity clean-up and reversed phase (C18) HPLC, with fluorescence detec-
tion (Scott et al., 1994). The reported recoveries for both fumonisins 
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averaged 79-109%, and the detection I imits were about 3-7 ng/ml. 
Aminopentol (AP1, the hydrolysis product of FB 1 ), was determined in milk 
by a combination of C18 solid phase extraction clean-up and reversed phase 
HPLC. A transmission study using four cows dosed with pure FB1 either 
orally (1 .0 and 5.0 mg FB1/kg body weight) or by iv injection (0.05 and 
0.2 mg FB1/kg body weight) showed no detectable residues of FB1 or AP1 in 
the milk, with or without hydrolytic treatment with ~-glucuronidase/sulfatase 
to liberate any conjugates. 
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Future research needs 
Future activities within the mycotoxin arena should address the Control 
System illustrated in Figure 11 in order to facilitate the effective operation of 
the four 'control' sub-systems: 
• identification of quality constraints 
• prevention of contamination 
• detoxification of contaminated feed 
• identification and segregation of contaminated material. 
The effective operation of these sub-systems requires the introduction of 
process quality management. This involves the formation of inter-disciplinary 
teams to address those key intra- and inter-commodity system interactions 
which determine the quality of the process-commodity matrix (see Figure 9). 
In order for these teams to operate successfully, the following general 
requirements should be met: 
• a better understanding of the aetiology of mould and mycotoxin pro-
duction in the field, including an evaluation of those moulds and myco-
toxins considered to be, potentially, of future importance; 
• a better understanding of the occurrence of mycotoxins in fruit and veg-
etables; 
• a better understanding of the human metabolism of mycotoxins; 
• a better understanding of the role of mycotoxins in the epidemiology of 
human disease; 
• the development of measures to prevent contamination (including dry-
ing and storage) which can be utilized by resource-poor communities in 
climatically-challenged environments; 
• the development of mould- and/or mycotoxin-resistant crop varieties; 
• the identification of detoxification procedures which yield a 'safe' product; 
• the introduction of harmonized sampling and analysis procedures. 
lt is essential that significant resources are directed towards obtaining a 
better understanding of the role of mycotoxins in the epidemiology of human 
disease. The establishment, for example, of a firm relationship between 
mycotoxin exposure and immunotoxicity would highlight the need to devote 
resources to the removal of mycotoxins from the human food chain, 
especially in those regions where high risk commodities constitute a major 
component of the staple diet. 
In order to facilitate the attainment of these requirements, work should 
continue with the development and validation of the following: 
• cost-effective sampling methods for a variety of mycotoxin/commodity 
combinations 
• rapid, simple, low cost mycotoxin analysis methods which can be used 
in unsophisticated laboratories 
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• biomarkers for the detection of exposure of individuals to mycotoxins, 
and for the detection of immunotoxicity 
• simple bioassays for the detection of toxic principles 
• short-term in vitro tests (reflecting both acute and chronic in vivo 
responses) using systems which have been transfected with human cyto-
chromes 
• gene probes for toxigenic moulds. 
Again, it is especially important that work should continue on the devel-
opment of biomarkers for the detection of exposure of individuals to myco-
toxins, and for the detection of immunotoxicity, as means of evaluating the 
nature of the relationship between mycotoxin exposure and immunotoxicity. 
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The Bulletin series features the results of research and practical scientific 
work carried out by the Natural Resources Institute. lt covers a wide 
spectrum of topics relevant to development issues ranging from land use 
assessment, through agricultural production and protection, to storage and 
processing. 
Each Bulletin presents a detailed synthesis of the results and conclusions 
within one specialized area, and will be of particular relevance to colleagues 
within that field and others working on sustainable resource management in 
developing countries. 
The mycotoxins attt·act world-wide attention because of the significant 
economic losses associated with their impact on human health, animal 
productivity, and both domestic and international trade. lt is likely that losses 
associated with human disease will be particularly significant in those 
developing countries where food staples, such as groundnuts and maize, are 
susceptible to contamination. In Mycotoxins and their Control: 
Constraints and Opportunities a systems approach to the occurrence 
and control of mycotoxins is adopted, which recognizes the interactions 
occurring within and between conceptual models of the commodity, 
spoilage, mycotoxin and control systems. Mycotoxins of 'world-wide', 
'regional' and 'future' importance are discussed, together with the 
metabolic fate of selected mycotoxins, and its exploitation in the 
development of biomarkers of mycotoxin exposure. Control measures 
discussed include breeding for resistance, the biocontrol of moulds and the 
chemical detoxification of contaminated feeds. Future research needs are 
also identified. 
This Bulletin will be of special interest to policy makers and researchers and 
to those involved in the production and utilization of foods and feeds, in 
human and animal health, and in the international trade of commodities. 
